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STELLINGEN: 
1. Bij gezonde vrouwen heeft het gebruik van laag-gedoseerde combinatie-contra-
ceptiva geen hypercortisolisme tot gevolg. 
Dit proefschrift. 
2. Het gebruik van laag-gedoseerde estrogeenbevattende orale contraceptiva leidt 
tot een verschuiving in de piek van Cortisol naar later in de ochtend. 
Dit proefschrift. 
3. Het metabolisme van Cortisol door llß-hydroxysteroiddehydrogenase in 
speekselklierweefsel resulteert bij de mens niet in corticosteron, maar in 
Cortison. 
Clin. Chim. Acta 183:217 (1989). 
4. Leeftijdsgebonden osteoporose bij vrouwen kan voor een groot deel voorko-
men worden door het levenslang slikken van de "pil". 
Voedingsmagazine 7:6 (1994). 
5. De foetale leeftijd, waarop een prematuur geborene nog in leven gehouden 
kan worden, ligt intussen niet ver meer af van het tijdstip, waarop nog legaal 
. een abortus gepleegd mag worden. 
Modern Medicine 19:38 (1995). 
6. De concentratie van pesticiden in regenwater is bij tijden zo hoog dat, 
wanneer deze in drink- of oppervlaktewater gevonden zou worden, dit een 
calamiteit genoemd zou worden. 
Chemosphere28:1559 (1994). 
7. Het aantal in Nederland toegelaten bestrijdingsmiddelen is in de jaren 1990-
1994 afgenomen. Wanneer vervallen middelen echter worden vervangen door 
meer potente en/of meer resistente middelen, is het effect op het milieu zeer 
dubieus. 
CBS (1994). 
8. De techniek van "molecular imprinting" van antigeenafdrukken in een poly-
meer zou wel eens het einde kunnen betekenen van het tijdperk van de 
antilichamen. 
Nature 361:645 (1993). 
9. Breed-spectrum antilichamen hebben voor een snelle screening in de water-
kwaliteitscontrole en de voedingsmiddelencontrole de voorkeur boven zeer 
specifieke antilichamen. Dit in tegenstelling tot immunoassays voor bijvoor-
beeld de klinische diagnostiek. 
Biol. Pharm. Bull. 17:843 (1994). 
10. De recovery van geaddeerde doelverbindingen kan sterk afwijken van de 
recovery van dezelfde endogene verbindingen. Bij evaluatiestudies moet hier 
terdege rekening mee gehouden worden. 
Kiwa Symp. nov. (1994). 
11. Immunoassays met behulp van een breed-spectrum antilichaam tegen ß-
agonisten kunnen goed toegepast worden in de screening op deze verboden 
groeimiddelen in vlees. 
Analyst 119:2671 (1994). 
12. ß-Cyclodextrine covalent gekoppeld aan de indicator methylrood reageert op 
de aanwezigheid van bepaalde organische moleculen met een kleurverande-
ring. Dit maakt dergelijke gastmoleculen geschikt voor de ontwikkeling van 
een sensor met unieke herkenningsmogelijkheden. 
Nature 356:136 (1992). 
13. Het is tot nu toe ondanks vele pogingen nog niet mogelijk gebleken een 
immunosensor voor pesticiden te ontwikkelen. 
Rapport RIKZ 94-047. 
14. In het kader van het Nederlandse drugsbeleid en uit het oogpunt van economi-
sche overwegingen kunnen drugsvangsten het beste gratis of tegen kostprijs 
verstrekt worden aan verslaafden. 
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D'eerste trouw 
Als van twee gepaarde schelpen 
D'ene breekt ofwel verliest; 
Niemand zal u können helpen 
(Hoe of je zoekt of hoe je kiest) 
Aan een, die met effen randen 
Juist op d'ander passen zou; 
D'eerste zijn de beste panden, 
Niet en gaat voor d'eerste trouw. 
Jacob Cats 
Aan mijn ouders en oma 
Introduction 
Abstract 
Cortisol in saliva is considered to be derived from the free, unbound fraction in plasma by 
simple diffusion through the salivary gland. Despite considerable conversion into cortisone 
in the salivary gland by the enzyme llß-hydroxysteroid dehydrogenase, levels of Cortisol 
in saliva form a good reflection of the free plasma fraction, which is considered to be the 
biologically active part. In the present study the relation between plasma free and salivary 
concentrations of Cortisol and cortisone were investigated in women with regard to the inf-
luence of hormonal status. Similarly, progesterone was measured in plasma and saliva 
during pregnancy to demonstrate the relation between plasma free and salivary progestero-
ne. In addition, the daily rhythm of Cortisol and cortisone and the influence of hormonal 
status was investigated on the basis of salivary levels. Further, the effect of processing of 
salivary samples on the concentration found for several steroids was determined. It appe-
ared that transport of corticosteroids from plasma to saliva is not a simple diffusion proces, 
but probably proceeds via specific binding proteins in the cell membrane at both the plas-
ma side and the saliva side of the gland cells. 
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List of Abbrevations 
F = Cortisol 
E = cortisone 
P = progesterone 
HPAA = hypothalamo-pituitary-adrenal axis 
CRH = corticotrophin releasing hormone 
CBG = corticosteroid binding globulin 
ABG = aldosterone binding globuline 
170HCS = 17-hydroxycorticosteroids 
UF = ultrafiltration 
ED = equilibrium dialysis 
CBA = Cortisol binding assay 
FCI = free Cortisol index 
AFCC = apparent free Cortisol concentration 
PC = paper chromatography 
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1. INTRODUCTION 
1.1. The Adrenal 
In the human endocrine system the adrenal is a very productive organ. From the more than 
40 steroids that have been isolated from the adrenal cortex, Cortisol is the main one found 
in the peripheral circulation. Its secretion amounts up to 25 mg (79 uM) each day. Cortisol 
belongs to the glucocorticoid hormones. This group of steroid hormones is named gluco-
corticoids because of their function in the glycogen metabolism in the liver. 
Already in 1938 the chemical structure of several adrenal steroids was elucidated [1,2]. At 
first, determinations of Cortisol concentrations were performed in urine with bioassays, 
being very insensitive and aspecific. In 1952 Nelson [3] described a method to measure 
adrenal steroids quantitatively in peripheral blood. The measuring of Cortisol included puri-
fication and the Porter-Silber method [4]. Development of the radioimmunoassay (RIA) 
increased the reliability, sensitivety and specificity of i.a. Cortisol determinations. 
Regulation of Cortisol synthesis is influenced by the hypothalamo-pituitary-adrenal-axis 
(HPAA) via a negative feedback system [5,6]. Adrenocorticotrophic hormone (ACTH) 
secreted by the pituitary induces the adrenal synthesis of Cortisol and high concentrations 
of Cortisol in turn inhibit the secretion of ACTH via a reduction of hypothalamic corticot-
rophin releasing hormone (CRH) secretion. Apart from the negative feedback system the 
secretion of Cortisol is regulated by a circadian rhythm and by stress mechanisms. The cir-
cadian rhythm is controlled by an intrinsic "biological clock" mechanism within the mid-
brain, and is mediated by variation in CRH secretion from the median eminence of the 
hypothalamus, causing the pituitary to release ACTH. The negative feedback system and 
the systems controlling the circadian rhythm are clearly interdependent. Independent and 
much more powerful is the control system which operates during stress. Physical or psy-
chological stress increases the secretion of CRH, ACTH and Cortisol, irrespective of the 
time of day or operation of the feedback [7]. 
1.2 Cortisol and protein binding 
Inherent to its property as a hormone, Cortisol is synthesized in an endocrine organ, the 
adrenal, and transported within the blood to its target tissues. In blood Cortisol exists not 
only in its free form but for the greater part it is bound to proteins, like many other hormo-
nes. The discovery of hormone binding, especially steroid binding, was made in the fifties 
(Forsham 1955 [8], Eik-Nes 1954 [9]) when it appeared that steroids were soluble in plas-
ma to a degree which was supraphysiological. In-vitro experiments indicated that albumin, 
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an abundant plasma protein, bound steroid hormones. By dividing plasma proteins in sever-
al fractions, the so-called Crohn's fractions, and performing ultrafiltration or equilibrium 
dialysis experiments, it could be demonstrated that Cortisol in plasma is bound to two pro-
teins, one with high capacity and low affinity, another with low capacity and high affinity 
[10-[12]). About the same time Daughaday (1958) [12] en Slaunewhite (1959) [13] succee-
ded in isolating this high affinity binding protein and they named it corticosteroid binding 
globulin (CBG) and transcortin, respectively. Since that time numerous studies have been 
performed exploring the nature, properties and significance of CBG, including chemical 
structure, binding sites, affinities, competition of natural and synthetic steroids, concentra-
tions in several pathological and non-pathological conditions. Summarizing, it appeared 
that: 
1. CBG is an alpha-glycoprotein, with a molecular weight of 52,000 Dalton; it is synthesi-
zed predominantly in the liver and it has a half-life in plasma of about 6 days [14]. 
2. CBG contains one specific binding site for several steroids which show varying binding 
affinities, the strongest binding being with Cortisol [15]. Relative affinities of CBG for 
steroids, assessed by displacement studies, revealed a descending affinity for Cortisol > 
desoxycortisol > corticosterone > prednisolone > 17-hydroxyprogesterone > desoxycor-
ticosterone > cortisone > progesterone > aldosterone > 11-hydroxyandrostenedione > 
androstenedione > dehydroepiandrosterone (Mills 1962) [16]. Depending on the method 
used variations in this order have been found. 
3. The distribution of Cortisol in blood is about 85% to CBG, 10% to albumin and 5% 
unbound in normal conditions [17]. These values have been found since the discovery 
of Cortisol and CBG and with minor variations have been stated in several studies [18-
20], A recent survey of the distribution of Cortisol between the blood compartments, esti-
mated by computer analysis, is given by Hiramatsu (1987) [21]. 
4. Concentrations of CBG have been measured in normal and diseased states. These inclu-
de healthy men and women, children, neonates, fetuses, during pregnancy, during estr-
ogen administration, in Cushing's or Addison's disease, in patients with diabetes, hypo-
gonadism, hirsutism, obesity, hypertension, dysproteinemia, affective disorders and 
many others. It is beyond the scope of the present study to discuss all these conditions, 
but a restriction is made to CBG concentrations in normal subjects, during pregnancy 
and after estrogen adminstration, with a side step to Cushing's disease. 
In normal healthy individuals the concentration of CBG is about 30-40 mg/1 [22-24]. 
Pregnancy or estrogen administration leads to a two to three fold increase in CBG levels, 
accompanied by a concomitant increase in the bound fraction of Cortisol [25-28]. 
The significance of CBG as a high affinity, low capacity cortisol-binding protein has been 
discussed since its discovery. About that time, 1957, Robbins and Rail [29] who adressed 
the transport of thyroid hormones, published their free hormone concept, implying that only 
the non-protein bound fraction of hormones diffuses freely out of capillaries to exert hormo-
nal effects. Several attempts have been made to ascertain that the free hormone concept is 
also applicable to Cortisol. Cortisol as a glucocorticoid hormone is i.a. involved in liver 
glycogen metabolism. In in vitro and in vivo experiments with mice, Matsui (1966) [30] 
demonstrated that CBG-bound Cortisol is inactive in liver glycogen deposition; Cortisol 
reduction in liver microsomes is reduced in the presence of CBG [31] and the negative 
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feedback mechanism is correlated with the free fraction of Cortisol [31-32]. 
In man, the best known clinical disorder of supraphysiological Cortisol levels is Cushing's 
syndrome, characterized, the very high Cortisol levels and the absence of a diurnal rhythm, 
as well as obesity, striae, hypertension and other features, which are all considered to be the 
result of excess of unbound Cortisol. 
The free hormone concept has been challenged from time to time and a long discussion has 
been carried on by the groups of Ekins and Partridge [33-38]. Those workers observed and 
calculated that not only the free but also the albumin-bound fraction of hormones is taken 
up by organs and that a variable fraction of CBG-bound hormone is taken up by organs like 
the liver and uterus, depending on the blood capillary transit time relative to the dissocia-
tion rate of the hormone from its transport protein. The appearance of CBG in extravascu-
lar fluids and the demonstration of specific CBG receptors, however, are some facts that 
contradict the free hormone concept [16,39]. 
Mendel's group has also made a considerable contribution to the discussion about the bio-
logical activity of free hormones [40-45]. They concluded that the free hormone hypothesis 
is not likely to be valid for all hormones with respect to all tissues. For Cortisol, e.g., it is 
likely to be valid, but for progesterone it may not hold at all. Nevertheless, the notion of 
only unbound hormones being biologically active continues to dominate. 
1.3. Elevated plasma Cortisol 
Cortisol determinations are widely used in assessing adrenocortical function. The first 
methods of measurement developed were rather unspecific, including 1. bioassay, i.e. gly-
cogen deposition in the liver [46]; 2. the amount of 17-hydroxycorticosteroids (170HCS) 
in urine [47] and 3. 170HCS in plasma [42]. 170HCS were determined fluorometrically 
[48-51] after extraction of the assay medium and sometimes after some kind of purificati-
on. 
An interest in adrenal function in pregnancy stimulated Venning (1946) [52] to investigate, 
with bioassay, the excretion of 17-ketosteroids and corticoids and she found an increase in 
urinary corticoids in the course of pregnancy. The increase in urinary 170HCS and a com-
parable elevation in plasma 170HCS was later stated [53] and according to Gemzell (1953) 
[54] the hypertrophic state of the adrenals was a well known phenomenon. The same incre-
ase in 170HCS was found when men with prostatic cancer or postmenopausal women were 
given estrogens [59,60] 
With rather specific methods Cohen (1958) [57] demonstrated that in pregnancy and after 
estrogen use Cortisol and its metabolite cortisone were raised in plasma, but comparable to 
normal values or even decreased in urine [58-60]. 
Overall, there were some conflicting data found in the fifties: urinary 170HCS, particular-
ly Cortisol, was considered as a measure of adrenocortial activity, but appeared to contrast 
increased 170HCS in plasma during pregnancy and estrogen administration [61-63]. Unlike 
patients with Cushing's syndrome, pregnant women and women using estrogens showed 
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no or minimal features of hypercortisolism, despite raised plasma corticosteroids. 
Differences between these two groups were i.a. the absence of a diurnal rhythm in Cushing's 
syndrome [64], which was preserved in the pregnancy or estrogen women [62,63], and a 
difference in CBG levels, which were in the normal range of even slightly decreased in 
Cushing's syndrome and two to three times higher in pregnancy or after estrogen administ-
ration [27]. 
From that time on the discussion about a state of hypercorticism or hypercortisolism in 
pregnancy or after estrogen administration was started and continued until recent times. 
1.4. Free Cortisol measurements 
Equilibrium dialysis (ED) or ultrafiltration (UF) are techniques that have since long been 
used for the separation of molecules of different size. The discovery that Cortisol in blood 
was for the greater part bound to proteins and the discrepancies found between levels of 
corticosteroids and clinical features of hypercorticism, was the first step towards a long 
series of attempts to measure the concentration of unbound Cortisol in blood or plasma. 
The methods applied, besides ED and UF, were ultracentrifugation, gelfiltration and char-
coal separation, in recent years also rate dialysis [65]. To acquire physiologically relevant 
results, the separation of bound and unbound Cortisol and subsequently the measurement of 
one of both fractions, requires that the equilibrium is not disturbed. Many conditions have 
been described that can lead to biassed results: temperature, dilution of sample, composi-
tion of reagentia, pH, leakage of membrane, etc. [27,61-72 a.o.]. 
The first experiments with regard to unbound corticosteroids were performed with ED and 
UF by measuring 170HCS in the sample and in the dialysate [53,73,74]. It is clear that this 
is a rather unspecific method. The availability of radioactive steroids was an improvement, 
but despite this the results from several groups were considerably inconsistent, especially 
when comparing plasma free Cortisol levels in normal conditions with those in conditions 
of elevated CBG. Methodological as well as fysiological factors made comparison of data 
difficult. The two main factors are: 1. Dilution of the plasma samples; 2. The time of samp-
ling. 
Ad.l. Sample dilution disturbs the equilibrium between bound and free fraction of Cortisol 
and this effect is different in plasmas with high or low CBG content. In most studies there 
was no correction made for the effect of dilution of the samples. 
Ad.2. The second main factor is the time of sampling and this is especially important for 
Cortisol which is secreted in a circadian rhythm with peak values in the morning that can be 
so high that the capacity of CBG is exceeded. As a result of this daily rhythm the concen-
trations of total bound and free Cortisol vary over the day [75]. 
About 5 % of Cortisol in blood is in the free form and equilibrium dialysis is the method of 
choice to determine the free fraction of Cortisol because with a minimal dilution of 1:1 and 
a thorough control of temperature (37°C), pH (7.4) and buffer composition (isotonic, phy-
siologic) disturbance of the equilibrium will be negligible. The theoretical and practical 
background of this assertion is described in the dissertation of Ross [76]. 
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1.5 Displacement of Cortisol 
As described in section 1.2, CBG contains one steroid binding site. Several steroids can 
bind to CBG with different affinities. The most extended study concerning the association 
of steroids to the three major plasma proteins in man, SHBG, CBG and albumin, was car-
ried out by Dunn (1981) [77] by measuring the relative binding activity and calculating the 
association constants for 21 endogenous steroids. With computer simulation and values for 
total plasma concentrations from literature, for each steroid was determined the % unbound, 
% SHBG-bound, % CBG-bound and % albumin-bound, in normal men, normal women 
during both follicular and luteal phase and in women during the third trimester of normal 
pregnancy. 
From the study of Dunn, the results for three steroids are extracted for this study: Cortisol, 
cortisone and progesterone. Besides the interest in Cortisol as the basis of this study, corti-
sone is included because it is the main metabolite of Cortisol in plasma and it is elevated in 
pregnancy. Progesterone is also increased in pregnancy and decreased after the use of oral 
contraceptives; besides it has strong affinity for CBG. When taking the results of Dunn 
(1981) it appeared that the relative binding activities were: Cortisol = 10 ± 0.4 x 105; corti-
sone = 1.2 ± x 10s; progesterone = 3.6 ± 0.5 x 105. With regard to the parameters calcula-
ted, taking into account that plasma values were taken from literature, the distribution of 
Cortisol, cortisone and progesterone was as follows: 
Table 1. Distribution of Cortisol in blood (from Dunn et al. 1981) 
Men 
Women 
(foil.) 
Women 
(lut.) 
Women 
(preg.) 
F 
E 
P 
F 
E 
P 
F 
E 
P 
F 
E 
P 
Total (nM) 
400 
72 
0.57 
400 
54 
0.65 
400 
54 
38 
740 
110 
480 
%Free 
bound 
3.91 
16.2 
2.39 
3.77 
15.8 
2.36 
3.90 
16.0 
2.38 
1.82 
11.0 
2.28 
%CBG 
bound 
89.5 
38.0 
17.2 
89.7 
38.6 
17.7 
89.4 
37.8 
17.2 
95.2 
59.1 
37.7 
% Albumin 
6.57 
45.3 
80.1 
6.33 
44.3 
79.3 
6.54 
44.9 
79.8 
2.2 
22.0 
54.7 
F = Cortisol; E = cortisone; P = progesterone; foil. = follicular; lut. = luteal; preg. = pregnant. 
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In normal men and women Cortisol is the major CBG ligand, occupying about 50% of the 
available CBG-binding sites, followed by cortisone with about 3%. In pregnancy, the decre-
ase of occupancy of CBG by Cortisol (about 40%) is primarily the result of competition by 
the marked increased progesterone (10.6% occupancy), whereas cortisone accounts for 
3.8% in this situation. 
The competition of Cortisol and progesterone for CBG binding sites during pregnancy, when 
progesterone concentrations are much more increased than those of Cortisol had earlier been 
described in detail by Rosenthal (1969) [78]. 
1.6. Salivary corticosteroids 
In 1957 Robbins and Rail put forward their free hormone concept. The available methods 
to measure adrenocortical steroid at that time were rather aspecific and it was acknowleg-
ded that errors in the determination of corticosteroids in plasma, total and/or free, could 
hide physiological significance. In 1955 Killman & Thayson [79] found that the concentra-
tion of the drug methylsulphanilamide in human parotid saliva followed closely that of the 
non-protein-bound drug in venous plasma. Burgen (1956) [80] stated that small non-ioni-
zed molecules could freely diffuse through salivary glands. In anticipating that salivary 
concentrations of synthetic or endogenous hormones might reflect the non-protein-bound 
fraction in blood, thereby giving a measure of the degree to which they might be available 
to tissue, a series of experiments was performed to assess adrenocortical activity on the 
basis of corticosteroids in saliva. 
The group of Shannon (1959 a,b, 1960) [81-84] demonstrated that in normal conditions as 
well as after the administration of cortisol-analogs or ACTH, 170HCS in parotid saliva 
parallelled plasma values. Greaves and West (1963) [85] using more specific methods for 
the measurement of Cortisol and cortisone in mixed saliva from pregnant and non-pregnant 
women, compared their values with plasma unbound Cortisol and cortisone values publis-
hed earlier [86,87]. Their conclusion was that salivary Cortisol was much lower than non-
protein-bound plasma Cortisol, whereas for cortisone the opposite was true. Furthermore, 
they stated that there is no binding of Cortisol and cortisone in saliva and also no enzymatic 
conversion, suggesting that salivary corticosteroids might reflect plasma free concentra-
tions, but in the case of Cortisol oxidation during the transit from plasma to saliva interferes 
in drawing definite conclusions. It has to be remarked that these authors already mentioned 
that the method used by them showed considerable error at low levels. 
The work of Katz and coworkers was continued leading to another series of publications 
(1964-1969) [88-96]. Summarizing the results until 1969 it appeared that: 
- the main corticosteroids in saliva are Cortisol and cortisone; 
- in saliva there is no binding of these steroids; 
- salivary concentrations parallel plasma dializable concentrations rather than total con-
centrations; 
- salivary Cortisol and cortisone exhibit a diurnal rhythm; 
15 
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- during the transit from plasma to saliva Cortisol is converted into cortisone (14C-Cortisol), 
whereas saliva itself contains no enzymatic activity; 
- measurements using Porter-Silber determinations result in a considerable overestima-
tion of corticosteroid levels. 
It has to be concluded that although measurement of salivary corticosteroids seemed pro-
mising for clinical researchers as a useful alternative to blood to gain more insight in 
adrenocortical status, it also became clear that the available methods were far from ideal. 
As already mentioned by Greaves and West (1963) [85], if hormones in saliva are expected 
to be a reflection of the non-protein-bound concentration in plasma, the first conditions to 
be met are that they diffuse freely from plasma to saliva, that they are not metabolized in 
transit and that there is no protein binding in saliva. Apart from the above mentioned, the 
methods used for the determination of salivary, plasma total and plasma free concentrations 
should provide reliable values. 
With regard to Cortisol in saliva the conversion into cortisone in the salivary gland is most 
probable, but it is possible that despite this conversion salivary Cortisol is still significantly 
correlated with plasma free Cortisol. In that case, salivary Cortisol determinations may be 
useful for assessing adrenocortical activity. 
1.7. Survey of literature 
In this section a survey of literature data concerning all aspects mentioned above will be 
given, including the concentrations of Cortisol, cortisone, progesterone and CBG measured 
in plasma and saliva as well as the methods used and also an overview of llß-hydroxyste-
roid dehydrogenase (1 lß-HSD). For reasons of clarity those data that were based on unrelia-
ble methods or where no sampling time was mentioned or where males were treated with 
estrogens are omitted, except for results in patients with Cushing's syndrome, because it is 
known that in that case no diurnal rhythm exists for corticosteroids [61]. 
1.7.1. Plasma free Cortisol 
From Table 2 it is clear that in patients with Cushing's syndrome plasma free Cortisol is 
always elevated far above normal values. In pregnancy, although to a lesser degree, plasma 
free Cortisol is also raised in the second and third trimester. The only exception are the 
results of Jerkunica et al. 1980 [97]. For women taking estrogens the data are varying. Some 
authors report elevated values, others report values not differing from normal. Remarkable 
are the findings of O'Connel & Wells (1969) [98] who demonstrated a difference in mean 
plasma free Cortisol in the course of the period of estrogen admininstration. At day 25 mean 
values were elevated above normal, whereas at day 5 they were not. 
16 
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1.7.2. Salivary Cortisol 
With regard to the reported data for salivary Cortisol (Table 3) in patients with Cushing's 
syndrome salivary Cortisol was elevated above normal, comparable to plasma free values. 
For pregnant women the results from the different investigators varied. A significant eleva-
tion was only found by Greaves & West (1963) [85] and by Laudat et al. (1987) [132]. For 
women taking estrogens there are only two studies with reliable results and in these the 
mean values for salivary Cortisol were in the normal range. 
7.7.3. Plasma free and salivary cortisone 
Plasma free and salivary cortisone have scarcely been measured in a way that comparisons 
were made between normal women and those women who had taken estrogens or were 
pregnant, although plasma free cortisone has been determined in cord blood [133]. The 
only data about salivary cortisone are given by Greaves & West (1963) [84], who stated 
that in pregnant women salivary cortisone (1.382 ± 0.485 ug/dl, n=31) is elevated above 
normal values (0.447 ± 0.218 ug/dl, n=20). These values are not totally reliable because for 
their measurements Greaves & West used fluorimetry and they stated themselves that a 
variation of about 30% is possible. 
7.7.4. Plasma free and salivary progesterone 
Regarding plasma free progesterone and salivary progesterone some more data are availa-
ble. Because it is an important hormone in fertility studies and often necessitates repeated 
sampling for which saliva has been found to be a good alternative for plasma sampling, 
salivary progesterone has often been measured during the normal menstrual cycle. 
Literature data about plasma free and salivary progesterone are shown in Table 4 and 5, 
respectively. 
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The values for plasma free and salivary progesterone show considerable variations, due to 
the indiviual changes in the course of the menstrual cycle. From Table 4 and 5 it is clear 
that both plasma free and salivary concentrations in the luteal phase are higher than in the 
follicular phase and that in the course of pregnancy the values steadily increase. 
It must be remarked that the percentage salivary progesterone relative to plasma total pro-
gesterone in pregnancy was found to be about 1-2 %, but in the normal menstrual cycle this 
percentage varied between the follicular and luteal phase from about 9 % to about 2 % 
respectively [138,140,145]. This difference can be ascribed to the level of CBG, the princi-
pal binding protein for progesterone, staying at the same level during the menstrual cycle, 
but increasing in the course of pregnancy, thereby keeping the percentage of salivary proge-
sterone at the same level. 
7.7.5. 11ß-Hydroxy Steroid Dehydrogenase 
The existence of the enzyme llß-hydroxysteroid dehydrogenase (llß-HSD) has been 
known since the elucidation of the steroid synthesis pathways in the adrenal cortex. Here 
llß-HSD catalyses the last step in the biosynthesis of Cortisol from 11-desoxyCortisol. 
Further oxidation of Cortisol to cortisone should also be possible in the adrenal cortex but it 
is generally assumed not to take place, although according to several reports cortisone is 
present in and secreted by the adrenals [147-149]. 
llß-HSD also plays a significant role in the metabolism of Cortisol, principally in liver and 
kidney. The reverse reaction, reduction of cortisone to Cortisol, also takes place in the liver. 
Cortisone is considered to be a metabolite of Cortisol with no biological function. Despite 
the fact that cortisone has since long been used as a therapeutic agent in, for example, 
patients with adrenal insufficiency, it is thought that before exerting its therapeutic effect 
cortisone has to be converted into Cortisol. In 1957 Peterson et al. [150] demonstrated that 
in adrenalectomized rats without liver the administration of cortisone had no effect as life-
saving corticosteroid. 
llß-HSD is an enzyme that stands for two activities, oxidase and reductase [151]. 
Interconversion of Cortisol and cortisone has been demonstrated in animals and man by stu-
dying the metabolism of radioactively labeled Cortisol and cortisone. llß-HSD activity is 
not only present in liver and kidney, but in several peripheral tissues [148,152,153]. A comp-
rehensive overview has been presented by Murphy (1981) [153], summarized in Figure 1. 
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Figure 1. Distribution ofllß-HSD activities in several human tissues. 
innu 
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Fig. 1. Interconversion of tracer Cortisol (F) and cortisone (E) in various tissues throughout life in the 
absence of added unlabeled substrate. Conversion from E to F is plotted to the left (stripes) while that 
from F to E is plotted to the right (dots). Means ± standard errors are indicated. 
Adapted from B.E.P. Murphy, J. Steroid Biochem. 14:811-817 (1981) with permission of the editor. 
From Figure 1 it appears that in adult man oxidation of Cortisol (F) to cortisone (E) predo-
minantly takes place in liver, gonads and lung. Reductive activity was found for the greater 
part in uterus, gonads, kidney, skin and lung. In contrast to adult man, fetal tissues show a 
clear predominance of oxidative activity in almost all tissues, being the highest in placenta. 
llß-HSD, at first observed in placenta by Osinsky (1960) [155], has since that time been 
subject of much study [152-165]. In 1974 Murphy et al. [156] demonstrated that the admi-
nistration of 3H-cortisol to a pregnant woman resulted in the presence in placenta of almost 
exclusively 3H-cortisone. 
From the results of Tanswell et al. (1977) [158] and Murphy (1977) [152] it appeared that 
in uterus as well as in placenta the dual action of llß-HSD changes from predominantly 
oxidative to predominantly reductive from the non-pregnant state to the pregnant state until 
term. 
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The function of 1 lß-HSD in placenta is considered to include the prevention of Cortisol 
reaching the young fetus because Cortisol acts as an inhibitor of growth and development 
of fetal tissues [166]. In the later part of gestation increasingly more Cortisol is needed for 
maturation of the fetal HPAA and lung tissue [167]. 
Apart from the above mentioned specific placental function and apart from liver metabo-
lism, according to Ferguson & McPhee (1975) [167] 1 lß-HSD is associated with tissues 
involved in water and electrolyte transport. The principal organ in the regulation of water 
and salt homeostasis is the kidney and 1 lß-HSD is present in kidney tissues. The salivary 
gland is also involved in the excretion of i.a. water and electrolytes. The presence of 1 lß-
HSD is salivary gland tissue was demonstrated in the dog [90] and the rat [167,168]. In 
man, salivary gland 1 lß-HSD is strongly suggested by the results of salivary Cortisol and 
cortisone measurements compared to plasma (free) values as discussed earlier. 
The activity of 1 lß-HSD, oxidase as well as reductase, is influenced by several factors. 
Among these are steroid hormones and there appears to exist a difference in substrate spe-
cificity depending on the tissue examined [148,162,163,169-171]. Moreover, some steroids 
can stimulate the activity of 1 lß-HSD, whereas others have an inhibitory effect, again 
depending on the particular tissue [154,161]. It may be remarked that for example proge-
sterone inhibits the conversion of Cortisol into cortisone. Product inhibition by cortisone 
has also been demonstrated, although in the reverse reaction Cortisol shows no product inhi-
bition. 
1.7.6. CBG 
Since the discovery of CBG in 1958 by Daughaday as the principal high affinity, low capa-
city binding protein for Cortisol and progesterone, this protein has been subject of much 
investigation. Part of this has already been discussed hereinbefore (see 1.2. Cortisol and 
protein binding). In the course of time several reviews concerning CBG have been publis-
hed [15,18,172-175]. 
The most extensive data about the binding of endogenous steroids (n=21) en drugs (n=70) 
have been published by Dunn et al (1981) [77] and Pugeat et al. (1981) [176]. 
1.8. Purpose of the study 
Holding to the still generally accepted view that salivary steroid levels are a true reflection 
of the free, biologically active fraction in plasma, this study was focussed on the relation 
between Cortisol and cortisone in saliva and free in plasma. Regarding the possible biasses 
in the available methods the assays were optimized. Special attention was given to samp-
ling time. 
Because the main interest concerned the influence of a simultaneous increase of CBG and 
total plasma Cortisol on the free plasma-saliva relations, in the first part of the study plasma 
and saliva samples were collected from a group of women using OC and a group of nor-
mally cycling women. In the second part of the study a group of pregnant women was fol-
lowed from the first trimester until term and they served as their own controls at 6 weeks 
postpartum. 
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The following parameters were determined: 
- plasma total and free Cortisol 
- plasma total and free cortisone 
- plasma CBG 
- salivary Cortisol and cortisone. 
In the pregnancy group the number of parameters was extended with: 
- plasma total and free progesterone 
- salivary progesterone. 
The main purpose of the study was to gain more information about the follo-
wing issues: 
1. Which (cor)relations exist between salivary and plasma concentrations of Cortisol and 
cortisone in the three study groups? 
2. Will, after OC usage or during pregnancy, the simultaneous increase in plasma total Cort-
isol and CBG lead to a hypercorticism at the level of plasma free Cortisol and is this re-
flected in saliva? 
3. What is the influence of llßHSD on salivary Cortisol and cortisone levels? 
4. Is salivary progesterone a reflection of plasma total and/or free progesterone? 
5. To what extent has the influence of the daily rhythm to be taken into account? 
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Summary 
The effect of a low estrogen oral contraceptive (OC) on glucocorticoid levels in plasma and 
saliva as well as glucocorticoid binding was studied in 23 healthy women using 30 ug ethi-
nyl estradiol (EE2) + 150 ug desogestrel (Marvelon®) (H). 
Fifteen healthy females with normal menses served as controls (I). Blood and salivary samp-
les were taken between 9.00 and 9.30 a.m. on the 18th day of menstrual or pill cycle. Assay 
accuracy had been optimised by applying extraction and chromatographic purification befo-
re radioimmunoassay (RIA) of Cortisol and cortisone in both plasma and salivary samples. 
Free steroid assays were performed by applying the same procedure to equilibrium dialysa-
tes obtained after dialysing plasma against an equal volume of buffer, instead of measuring 
tracer distribution. Corticosteroid Binding Globulin (CBG) was measured by a commercial 
RIA. As expected, CBG as well as plasma total Cortisol were elevated in the pill group. 
Interestingly both plasma free and salivary Cortisol were higher than in controls (free Corti-
sol I: 18.0 ± 7.95 nmol/1; II: 32.3 ± 9.03 nmol/1; salivary Cortisol I: 9.2 ± 3.88 nmol/1; II: 
18.8 ±6.92 nmol/1. Salivary Cortisol closely parallelled plasma free Cortisol both within and 
between the groups, though at a much lower level (about 50%). Free cortisone was slightly 
lower in the pill group (I: 10.8 ± 2.55 nmol/1; II 8.5 ± 1.86 nmol/1) whereas salivary corti-
sone was 2.3 (I) and 4.4 (II) times higher than plasma free cortisone and tended to follow 
the plasma free and salivary Cortisol pattern, both within and between the study groups. 
These latter observations were taken as suggestive of the presence of llß-hydroxysteroid 
dehydrogenase (1 lßHSD) in the salivary gland, converting part of the entering Cortisol into 
cortisone. Nevertheless, salivary Cortisol must be considered to reflect adequately the 
increased plasma free Cortisol during OC-administration. 
Introduction 
The estrogen-induced rise in plasma Cortisol and its principal carrier protein CBG has been 
known for a long time [1,2]. However studies on plasma free Cortisol levels during OC-use 
have hitherto led to contradictory results [3-20]. The large variety in the reported observa-
tions can at least partly be ascribed to assay methodology. Furthermore, the diurnal rhythm 
in Cortisol secretion makes sampling time a critical factor. 
Most of the steroid hormones in plasma have been detected in saliva as well. Salivary levels 
of the unconjugated steroids are usually in the same order of magnitude as their correspon-
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ding free concentrations in plasma [21,22]. This suggests that salivary steroid hormones 
derive directly from the plasma free moiety. Obvious advantages of saliva as a medium for 
hormone assay are its ease of accessibility and the stress-free conditions for obtaining samp-
les. Also, methodological problems involved in free hormone assay can be circumvented. 
The few literature date available [23,24] indicate that salivary Cortisol remains within the 
normal range during OC use. Furthermore, it has been demonstrated that salivary levels of 
Cortisol are substantially lower than plasma free levels [25,26], possibly due to metabolic 
conversion of Cortisol to cortisone by an 11-hydroxy steroid dehydrogenase (llß-HSD) in 
the salivary gland [6,27]. 
This report presents the results of the measurements of plasma Cortisol and cortisone, both 
total and free, and their respective salivary levels in a group of healthy women using an OC 
combination of ethinyl-estradiol and desogestrel, and in healthy controls with normal men-
ses. To minimize methodological artefacts, free Cortisol and cortisone were assessed by 
equilibrium dialysis of plasma against an equal volume of buffer, followed by highly speci-
fic RIAs including extraction and chromatographic purification of the free hormone in the 
dialysate. The same RIAs were employed for total and salivary steroids. 
Materials and methods 
Subjects 
All subjects cooperating in this study were healthy female volunteers, aged 18-45 yr with a 
history of regular menses. The control group (I) consisted of 15 women with a normal 
menstrual cycle. The OC group (II) included 23 women taking ethinyl estradiol 30 ug + 
desogestrel 150 ug (Marvelon®). The subjects in group II had been using the same prepara-
tion for at least 6 mth. 
Sampling 
Matched samples of blood and saliva were taken at 9.00-9.30 h a.m. at day 18 of the menst-
rual or pill cycle. Blood was drawn into heparinized tubes, centrifuged and the plasma sto-
red at -20°C until analysis. Citric acid stimulated saliva was collected in plastic cups, fro-
zen at -20°C and sonicated after thawing. 
CBG 
Plasma CBG concentrations were determined with a CBG RIA kit purchased from 
Medgenix, Brussels, Belgium. 
Plasma total and salivary Cortisol and cortisone 
For the determination of total plasma and salivary Cortisol and cortisone 0.2 ml of plasma 
or 0.7 ml of saliva were incubated with ±10.000 dpm of recovery tracer (l,2,6,7-3H-cortisol 
83.5 Ci/mmol and l,2-3H-cortisone 29 Ci/mmol) for 30 minutes. The samples were extrac-
ted with 14 ml of dichloromethane and the extracts dried under a stream of clean air. 
Residues were applied on Whatman no. 1. paper and chromatographed in a descending 
Bush B5 solvent system (toluene:methanol:water 2:1:1). After radioactivity scanning, the 
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peaks were eluted in 2 ml ethylene glycol in water (EGW) and the eluated used in the RIA 
and for recovery counting. Standard curves were set up in duplicate. After overnight incu-
bation at 4°C the bound and free fraction were separated with dextran-coated charcoal. 
Free plasma Cortisol and cortisone 
For the determination of the free plasma concentration of Cortisol and cortisone 0.8 ml of 
plasma was dialysed against 0.8 ml buffer (0.05 mol/1 phosphate, 0.1 mol/1 NaCl, pH 7.40) 
for 3 h in a Diachema dialysis apparatus. The concentrations of the hormones were meas-
ured in the dialysate using the same procedure as described for total plasma and salivary 
Cortisol and cortisone. The free fractions / o ' and the free hormone concentrations Fo' were 
estimated for undiluted plasma using a formula that takes into account the dilution (1:1) 
implicit in equilibrium dialysis: 
/0 '=1/(H</F-V/V0+1) 
F o ' = H o x fo< 
where: Ho = total hormone concentration (nmol/l; F = (free) hormone concentration as measured in 
dialysate; Vf Ab = ratio of total volume of dialysis system to sample volume, which for the present 
case equals 2. 
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Fig. 1. Concentrations of CBG, Cortisol (F) and cortisone (E) in plasma and saliva in group I (con-
trols) and group II (pill). Mean values ±sd: CBG: I892 ± 123 nmol/l; II1534 ± 284 nmol/l; plasma 
total F: 1394 ±394 ± 107 nmolA; II1284 ± 315 nmol/l; plasma total E: 152 ± 10.4 nmolA; II59 ± 
10.6 nmol/l; plasmafree F: 118.1 ± 7.95 nmol/l; II 32.3 ± 9.03 nmol/l; plasma fee E: 110.8 ± 2.56 
nmol/l; II 8.5 ± 1.86 nmol/l; salivary F: 19.2 ± 3.88 nmol/l; II 18.8 ± 6.92 nmolA; salivary E: 124.2 
± 5.43; II36.7 ± 8.45. Significance levels (t-test): ***p<0.0001; **p<0.01; n.s., not signifant. 
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Results 
The results of determinations of the CBG, total and free plasma as well as salivary Cortisol 
and cortisone concentrations are shown in Fig. 1. In the OC group, CBG and total plasma 
Cortisol were significantly elevated with respect to the control group. Although elevated 
CBG leads to a substantial reduction of the percent free Cortisol, the mean free Cortisol 
concentration was significantly higher than the mean of control values. Salivary Cortisol 
levels parallelled plasma free levels, both within and between groups (Table I). The absolu-
te levels of salivary Cortisol, however, were lower than plasma free Cortisol by a factor 2. 
Table 1. 
Comparison of plasmafree and salivary Cortisol (F) and cortisone (E) in the control (I) and the pill 
(II) group. 
t-test 
a 
a 
FF, plasmafree Cortisol; SF, salivary Cortisol; FE, plasmafree cortisone; SE, salivary cortisone; sig-
nificance levels: a= p<0.0001; &= p<0.001; c= p< 0.01; " = p<0.05; corr, correlation coefficient 
(Pearson); n.s = not significant. 
Plasma free cortisone was slightly but significantly reduced (p<0.01) as compared to con-
trols. Salivary cortisone exceeded free cortisone considerably. A significant correlation 
between the two parameters existed within groups (Table I), but their ratio differed appre-
ciable between groups. Salivary cortisone concentrations were more or less similar to plas-
ma free Cortisol values. Moreover, the within group correlations between salivary cortisone 
and free Cortisol were as good as or even better than between salivary and free cortisone 
(rj = 0.64, Ï2 = 0.76), and taking the two groups together, the correlation between salivary 
cortisone and free Cortisol remains highly significant (r = 0.84, p < 0.001), whereas the cor-
relation with plasma free cortisone disappears (r = 0.04, n.s.). These findings suggest that 
plasma free Cortisol contributes significantly to salivary cortisone. 
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FF(nmol/l) 
SF(nmol/l) 
Ration SF/FF 
Corr. SF/FF 
FE(nmol/l) 
SE(nmol/l) 
Ration SE/FE 
Corr. SE/FE 
I 
(controls) 
(n=15) 
18.1 ±7.95 
9.2 ±3.88 
0.52 ±0.11 
0.92 b 
10.8 ±2.56 
24.2 ±5.43 
2.29 ±0.44 
0.66 c 
II 
(EE2+desogestrel) 
(n=23) 
32.3 ±9.03 
18.8 ±6.92 
0.58 ±0.12 
0.81 b 
8.5 ±1.86 
36.7 ±8.45 
4.44 ±1.03 
0.48 d 
The effect of oral contraceptives on plasmafree and salvary Cortisol and cortisone 
Discussion 
The well-known effect of estrogen administration on hepatic CBG synthesis, its plasma 
level and the concomitant rise in total Cortisol is apparent also with low dose estrogens. 
According to the present results, both plasma free and salivary Cortisol are elevated too. 
Others [7-10,13] have reported elevated free Cortisol levels, but unmodified free Cortisol 
during OC use also has been found [19]. By the application of equilibrium dialysis at the 
lowest dilution that is technically feasible, using a buffer with physiological pH, ionic 
strength and chloride concentration, and employing a highly specific RIA with chromato-
graphic prepurification for free hormone determination in the dialysate, not much room 
seems to be left for doubting the validity of the assay results. The observation seems howe-
ver to conflict with the free hormone concept [28], which implies that the free hormone 
concentration reflects its bioavailability. This would raise the question why no overt clini-
cal signs of hypercorticism are observed. As it is uncertain whether this observation, which 
is done between 9.00 and 9.30 a.m., is representative of the average daily exposure of the 
body to glucocorticoid action, the elevated free and salivary Cortisol may merely reflect a 
shift of the morning peak of Cortisol. Alternatively the observation would be consistent with 
anti-glucocorticoid action of one of the components of the OC preparation, both at the pitui-
tary and target organ level. 
A relatively tight relation exists between salivary and plasma free Cortisol (Table I). 
Correlation is highly significant within both control and OC groups, and the mean ratio 
salivary/free Cortisol is almost the same for control and OC subjects. This explains why the 
correlation further improves when all observations are taken together. Remarkably, salivary 
Cortisol is only 50% of its plasma free counterpart, but nevertheless may be considered as 
representative of free Cortisol in OC users and non-users by virtue of the above mentioned 
relations. This is in line with other observations [22,26], showing that salivary Cortisol clo-
sely parallels the pattern of free Cortisol. The relation between salivary and plasma-free 
cortisone appears to be much less unambiguous. Within both groups, a significant correla-
tion exists, which however disappears when the two groups are taken together. This is 
because the ratios of salivary to free cortisone differ widely for controls (2.3) and subjects 
on OC (4.4). The fact that these ratios are well over unity in both cases suggests the presen-
ce of an additional source of salivary cortisone. Remarkably, there is a significant correla-
tion between salivary cortisone and plasma free Cortisol which is as good as or even better 
than with free cortisone, and which does not disappear when combining the two groups, 
but rather improves. These findings, together, with the indications of the presence of l lß-
HSD in the salivary gland [6,27], led us to hypothesize that salivary cortisone originates 
for one part from plasma free cortisone and for the other part from conversion of Cortisol 
into cortisone in the salivary gland. This would also account for the fact that apparently 
some Cortisol is 'lost' at the transition from plasma to saliva. 
In summary the following conclusions are drawn. During EE2/desogestrel use, both plasma 
free and salivary Cortisol increase appreciably. A ratio of approximately 2:1 between these 
two parameters exists normally and remains in the presence of high CBG levels induced by 
the OC combination administrated. Therefore, salivary Cortisol may be considered as an 
adequate parameter reflecting plasma free Cortisol. This does not count for salivary cortiso-
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ne. It exceeds free cortisone by a factor that is strongly related to free and salivary Cortisol. 
The observations are consistent with the presence of cortisol-to-cortisone converting activi-
ty-
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ABSTRACT 
To see if saliva is a valid substitute for plasma in assay of progesterone even when concen-
trations of hormone and binding proteins are fluctuating, we determined the concentrations 
of total and free progestrone in plasma and salivary progesterone from 36 women volun-
teers during the course of pregnancy and six weeks postpartum, using a highly specific RIA 
after extraction and chromatographic purification of the steroid. The free fraction in plasma 
was determined via equilibrium dialysis, followed by the same RIA analysis for progester-
one in the dialysate. Desspite the dramatic increases in concentrations of total progesterone 
and binding proteins in plasma during pregnancy, we found highly significant correlations 
between total and free progesterone in plasma and salivary progesterone in the group as a 
whole as well as individuals (P <0.001 in almost all cases). The proportion of free proge-
sterone in plasma and of salivary progesterone relative to total progesterone in plasma 
remained constant at about 1 % and 0.5 %, respectively, whereas during the postpartum 
period there was much more variance. Evidently salivary progesterone is a very good alter-
native to plasma as a sample for use in follow-up during pregnancy. 
INTRODUCTION 
Since the discovery that steroid hormones are present and measurable in saliva (1), the cli-
nical advantages of using this kind of sample for their determination have been described 
several times (2-5). Concentrations of unconjugated steroids are quantitatively similar to 
the free fractions in plasma. Total and free concentrations in plasma and in saliva correlate 
well. The free moiety of steroid hormones in plasma relates to their biological activity (for 
review, see reference 6). For these reasons the use of saliva has clinical as well as scientific 
interests, especially in situations characterized by altered concentrations of binding pro-
teins. 
During pregnancy, concentrations of steroids and steroid binding proteins in blood are rapid-
ly changing, making samples of pregnant women eminently suitable for the study of correla-
tions between saliva and plasma steroids over a wide range of values. We were especially 
interested in progesterone, a hormone synthesized by the adrenals and gonads and, during 
pregnancy, by the placenta. Its total concentration in plasma increases from <10 ug/L in the 
follicular phase to about 170 ug/L at term (7-10). 
During the menstrual cycle, when changes in progesterone concentrations are less dramatic 
than during pregnancy, salivary progesterone gives a good reflection of progesterone con-
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centrations in plasma, although authors disagree about the actual concentrations in saliva 
and about the correlations between salivary and plasma concentrations of progesterone (11-
13). During pregnancy, again, the enormous increase in plasma progesterone is reflected in 
saliva (14,15). Unfortunately, few studies have dealt with the relation between total and 
free progesterone in plasma and that in saliva throughout gestation. Darne et al.(15) demon-
strated an excellent correlation between free progesterone in plasma and salivary proge-
sterone in the second half of pregnancy, but contradictory results were published by Perry 
et al.(9). 
In our study we assayed matched blood and saliva samples from 36 pregnant women during 
gestation and postpartum. Total progesterone in plasma and salivary progesterone were 
determined with a highly specific and sensitive RIA, including chromatographic purifica-
tion before assay. Free progesterone in plasma was determined by equilibrium dialysis, fol-
lowed by RIA of the dialysate. 
Materials and methods 
Subjects and sampling 
Thirty six healthy pregnant women, attending the Gynecologic Clinic of the St.Jozef 
Hospital in Doetinchem for obstetrical reasons, volunteered in this study. 
Matched blood and saliva were sampled four times during pregnancy - during weeks 14-19 
(period 1), weeks 20-26 (period 2), weeks 27-34 (period 3), and weeks 35-40 (period 4) -
and once at six weeks postpartum (period 5). From half of the women we collected blood 
and saliva specimens at 0900-1000 h, and from the other half at 1500-1700 h. Blood was 
drawn into heparinized tubes, centrifuged (5 min at 1500 x g), and the plasma was stored at 
-20 °C. Saliva was collected in plastic cups and frozen at -20 °C. Before use it was thawed, 
centrifuged (10 min at 1500 x g), and the supernatant liquid was used for the analysis. 
Methods 
For the assay of total progesterone in plasma and salivary progesterone we incubated 0.2 
and 2.0 mL samples, respectively, with recovery tracer, about 10 000 dpm [1,2,6,7-3H]-
progesterone (4.07 PBq/mol, New England Nuclear Corp., Boston, MA), for at least 2 h. 
We then extracted the samples with 15 ml of diethyl ether. The residues were applied to 
Whatmann no. 1 paper strips and chromatographed in a descending Bush B3 solvent system 
[petroleum ether (b.p. 80-110°)/toluene/methanol/water, 133/167/400/100, by vol]. All 
chromatography solvents were of "Baker Analyzed" grade (J.T.Baker Chemical Co., 
Phillipsburg, NJ). After chromatography was completed we scanned of the paperstrips for 
radioactivity and eluted the progesterone peaks (Rf = 0.88) in 2.0 mL of borate buffer (0.1 
mol/L, pH 8.0) containing 5 g bovine serum albumine per liter. The eluates were used for 
assessing analytical recovery and RIA. 
In the RIA three different volumes of eluate were incubated with [3H] -progesterone and 
antiserum (raised against progesterone-11-hemisuccinate-BSA, a gift from Organon, Oss, 
The Netherlands). After incubation for at least 2 h at 4 °C the bound and free fractions were 
separated by use of dextran-coated charcoal. The detection limit of the RIA (3 SD from the 
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mean of the zero standard, n = 10, was 1.5 pg/tube. The procedural recovery was about 50 
%, resulting in a detection limit of 90 ng/L for total progesterone in plasma and 10 ng/L for 
salivary progesterone. Interassay CV was 8.4 % for progesterone concentrations of 1 ng/L 
(n=48). The intra-assay CV for total progesterone in plasma at 125 ng/L was 8.1 % (n=10). 
The intra-assay CV for salivary progesterone at 0.6 ng/L was 6.7 % (n=10). 
The free fraction of plasma progesterone was determined by equilibrium dialysis according 
to the method of Meulenberg et al.(16), briefly described as follows. We dialyzed 0.8 mL 
of plasma against 0.8 mL of sodium phosphate buffer (50 mmol/L, pH 7.40) for 3 h at 37 
°C. After dialysis the concentration of progesterone in the dialysate was determined by the 
same procedure as for total progesterone in plasma. After correction for sample dilution 
(1:1) in the equilibrium dialysis, we calculated the free progesterone concentration in plas-
ma. 
For statistical analysis of the results we used Student's t-test and Pearson regression analy-
sis. 
Results 
Figure 1 illustrates the courses of the concentrations of progesterone in plasma and saliva 
during pregnancy and six weeks postpartum. Because half of the samples were collected at 
0900-1000 h and the remaining half at 1500-1700 h, we have separated the values for mor-
ning and afternoon. Shown are the mean concentrations of progesterone at periods 1 to 5. 
In the samples collected in the morning, mean total progesterone concentration increased 
from 48 ug/L in period 1 to 170 ug/L in period 4, then sharply declined to 1.5 ug/L in period 
5. The mean concentrations in the afternoon samples showed the same course: an increase 
from 41 ug/L to 180 ug/L and then a decrease to 4.4 ng/L. We detected no statistically sig-
nificant differences between morning and afternoon samples (Student t-test) (Figure la). 
Free progesterone in plasma increased from 0.6 ng/L to 2.2 ng/L from period 1 to 4, then 
decreased to 0.12 ng/L postpartum in the morning samples. In the afternoon samples the 
mean concentrations were 0.47, 1.75 and 0.09 ng/L, respectively. Plasma free progesterone 
concentrations in morning and afternoon samples were significantly different (P <0.05 by 
Student's t-test) during pregnancy, with higher values in the morning (Figure lb). 
The mean concentration of progesterone in the corresponding saliva samples, although 
about 50 % lower in absolute values, showed the same pattern as for plasma free progester-
one. It increaes from about 0.20 ng/L in period 1 to about 0.90 ng/L in period 4, and then 
declined to a mean of 0.03 ng/L at six weeks postpartum (Figure lc). There was no statisti-
cally significant difference between samples collected in the morning and afternoon. 
Most of the progesterone in plasma is bound to proteins (corticosteroid binding globulin, 
albumin), only 1-2 % being in the free form. We found that during pregnancy (periods 1 to 
4), the percentage of free progesterone relative to total progesterone in plasma (= 1 %) 
varied little, even though the latter increased to about 100 times postpartum values. Post-
partum, the mean proportion of free progesterone in plasma was 10-17 % (Figure 2a). 
Progesterone in the corresponding saliva, expressed as the mean percent of the total proge-
sterone in plasma, was also more or less constant during pregnancy, varying from 0.45 % 
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Figure 1. 
The mean (± SEM) concentrations of total (a), 
and free (b) progesterone in plasma, and sali-
vary (c) progesterone during pregnancy and at 
six weeks postpartum. 
* P < 0.05 Student's t-test, difference between 
morning (AM) and afternoon (PM) samples; 1) 
not significant. 
Figure 2. 
The mean (± SEM) percentages of (a) free 
progesterone in plasma and (b) salivary proge-
sterone relative to total progesterone in plas-
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to 0.56 %. Postpartum, it was 5-6 % (Figure 2b). 
The correlations among the three parameters (Figure 3) were highly significant Table 1). 
Despite the small number of observations per person, correlation coefficients and P-values 
for individual subjects were almost without exception highly significant. An example is 
given in Figure 4. 
Table 1 
Comparison of total and free progesterone in plasma and salivary progesterone. 
A 
B. 
Variable 
TPvsFP 
TPvsSP 
FPvsSP 
TPvsFP 
TPvsSP 
FPvsSP 
Line 
y = 0.010 x +0.133 
y = 0.005 x + 0.021 
y = 0.408 x +0.013 
y = 0.011x + 0.135 
y = 0.005 x + 0.038 
y = 0.516 x-0.028 
r 
0.8897 
0.9015 
0.8828 
0.9964 
0.9998 
0.9951 
n 
173 
175 
173 
5 
5 
5 
P 
0.0001 
0.0001 
0.0001 
0.0005 
0.0001 
0.0005 
SD(y) 
0.0004 
0.0002 
0.0168 
0.0005 
0.0001 
0.0298 
TP = Total progesterone in plasma, FP = free progesterone in plasma, SP = salivary progesterone; 
all values are in pg/L. 
r = correlation coefficient (Pearson), n = number of subjects, P = significance level, SD(y) = stan-
dard deviation ofy; A, all samples; B, one subject. 
Discussion 
In agreement with many former studies, our results illustrate the dramatic increase in total 
progesterone in plasma during pregnancy, with mean maximum values of about 170 ug/L 
at term. We found a similar increase for free progesterone in plasma and salivary progester-
one (mean maximal values of about 2.0 ug/L and 0.90 ug/L, respectively) (Figure 1). The 
three variables werd highly significant correlated (P <0.001) for the study group as a whole 
as well as for individual subjects. Thus we conclude that salivary progesterone gives a very 
good reflection of total as well as of free progesterone in plasma during gestation. 
Although the proportions of free progesterone in plasma and salivary progesterone relative 
to total concentrations in plasma remained constant during pregnancy at about 1 % and 0.5 
%, respectively, we found much higher proportions, with considerable variation, post par-
turn (Figure 2). Considerable variations in the ratio of salivary progesterone to plasma total 
progesterone during the menstrual cycle have been reported by others (10,17). Our finding 
that mean free concentrations in plasma were significantly higher than salivary concentra-
tions is in line with data presented by Darne et al.(15). The fact that steroid-metabolizing 
enzymes have been found to be present in salivary glands (16,18-20) and gingival tissue 
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(21) may provide an explanation for this phenomenon. A second explanation for the discre-
pancy may be the loss of progesterone during centrifugation of the saliva before analysis. 
From the study of Lequin et al.(22) it appeared that the centrifuged cell debris of saliva 
contained disproportionately high amounts of progesterone. Nevertheless, diminished 
concentrations in saliva apparently do not disturbe the correlation between plasma and sali-
va. 
We divided our study group in a morning and an afternoon group with respect to sample 
collection. The respective results for these two groups (Figure 1) show that only for free 
progesterone in plasma was there a statistically significant difference between the means 
for morning and afternoon samples during periods 1 to 4, with higher values in the mor-
ning. A possible explanation for this finding lies in the daily rhythm of Cortisol and the 
competition of progesterone and Cortisol for their combined binding protein, the corti-
costeroid-binding globulin. The two steroids bind to the latter at the same place and with 
almost the same affinity (23,24). During the morning peak of Cortisol, progesterone will be 
displaced from corticosteroid-binding globulin, resulting in an increased proportion of free 
progesterone (8,25). We did not find this daily variation to be reflected in progesterone con-
centrations in saliva. This finding can be explained with the assumption that the competi-
tion between Cortisol and progesterone continues during the passage from blood to saliva 
via the salivary gland. Accordingly, we tend to believe that the transport of steroids is not 
merely a process of passive filtration, but rather an active process, a view already postula-
ted by Lequin et al.(22). 
In conclusion, it is clear that during pregnancy the increase in total progesterone concentra-
tions in plasma is reflected both in the proportion that is free in plasma and in the concen-
trations in saliva, with highly significant correlations among these three parameters for our 
study group as a whole as well as for individual subjects. Consequently, saliva is an excel-
lent alternative to plasma for the analysis of progesterone for follow-up during pregnancy. 
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SUMMARY 
We investigated the effect of the pretreatment (sonification or centrifugation) of saliva 
samples on the concentration of several steroid hormones as measured with highly specific 
RIA after extraction and chromatography. It appeared that sonification of saliva resulted in 
significantly higher values for progesterone, cortisone, 17-hydroxyprogesterone, testostero-
ne and estradiol (10 - 49 % increase), compared with the levels recorded after centrifugation 
of the samples. No differences were demonstrated for the concentrations of Cortisol and 
androstenedione, except that a sex-dependent difference was observed in the values for 
androstenedione: concentrations measured in sonificated male saliva were lower than those 
measured in supernatant saliva. 
INTRODUCTION 
Hitherto, the rationale of steroid assays in saliva was based on several assumptions: 
1. that the plasma free, protein-unbound, apolar steroid hormones freely diffuse through 
the salivary gland, 
2. that the concentrations of these steroids in saliva are comparable to their plasma free 
levels, 
3. that steroid binding proteins are absent from saliva (1,2). 
Indeed, many authors report a very close relationship between the plasma free and salivary 
concentrations of several endogenous steroids, synthetic steroids and even drugs (3-9). The 
very fast (infusion-studies) and flow rate-independent appearance of apolar steroids in sali-
va strengthened the idea of an unhampered diffusion from plasma to saliva (10). In those 
cases where salivary concentrations did not reflect their plasma free levels, or where plas-
ma free and salivary concentrations were quite different, this was explained by assuming 
the presence of steroid metabolizing enzyme activities in the salivary gland or by methodo-
logical imperfection (11-15). 
However, it was later demonstrated that steroids in saliva exist only partly in the unbound 
state (4,16-20). The assumption that only apolar, lipid-soluble or small polar compounds 
could enter the saliva by diffusion or ultrafiltration, respectively, had to be reconsidered 
when several proteins were detected in saliva (21-28). The most disturbing finding, which 
may result in a re-evaluation of the current concepts in salivary steroid assay, is the detec-
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tion of specific steroid binding proteins in saliva: corticosteroid binding globulin, sex hor-
mone binding globulin, aldosterone binding globulin (29-32). According to Chu & Ekins 
(1989), corticosteroid binding globulin in saliva, which is highly dependent on flow-rate, is 
not merely a contamination, but should be regarded as a secretion product, originating from 
plasma. 
The generally applied technique of saliva preparation before assay is freezing, thawing and 
centrifugation, which produces a clear, easily pipettable supernatant. Freezing and thawing 
of saliva, however, results in precipitation of globular proteins (23), whereas centrifugation 
leads to a considerable loss in protein content (33). If specific steroid binding proteins are 
present in saliva the preparation of samples before assay may greatly influence the results 
of steroid hormone determinations, especially when direct assays are used. We were inte-
rested whether the method of pretreatment salivary samples (centrifugation or sonification) 
would influence the concentrations of several steroid hormones, which were assayed with 
highly specific RIA after extraction and chromatography. 
MATERIALS AND METHODS 
Subjects 
For this study 111 healthy, non-medicated subjects volunteered for the collection of saliva. 
The group consisted of 20 men, 17 pregnant women and 74 non-pregnant women, aged 15 
- 60 year. 
Sample collection 
Each subject provided 15-20 ml of saliva. Citric acid grains were applied to the tongue to 
stimulate flow and the saliva was spat into plastic cups. After sampling, the saliva was 
immediately frozen and kept at -20°C until analysis. 
Sample preparation 
The saliva samples were thawed at room temperature. After thorough mixing, each sample 
was divided in two portions. One portion was centrifuged for 10 minutes at 1500 g, which 
yielded a clear saliva supernatant. The other portion was sonificated (2 times 30 secondes) 
with a MSE Soni-prep 150 (MSE Scientific Instruments, Manor Royal, Crawbey, Sussex, 
England) and was referred to as whole saliva. 
Materials 
Chromatography solvents were of "Baker Analyzed" grade (J.T. Baker Chemical Co., 
Phillipsburg.NJ). All other chemicals were analytical grade. The pure steroids were purcha-
sed from Steraloids (Steraloids INC., Wilton, NH). Tritiated Cortisol, cortisone, testostero-
ne, progesterone, androstenedione and estradiol were purchased from New England Nuclear 
Corp., Boston, MA. Tritiated 17a-hydroxy-progesterone was from Amersham Int. PLC, 
Amersham, England. The Cortisol and cortisone antisera were a gift from Prof.Vecsei, 
Heidelberg, FDR; testosterone antiserum was a gift from Dr.Pratt, Groningen, The 
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Netherlands; progesterone and estradiol antiserum were from Organon, Oss, The 
Netherlands; androstenedione antiserum was purchased from Radio Assay Systems 
Laboratories Inc., Carson, CA; 17-hydroxy-progesterone antiserum was raised in sheep in 
the endocrinology division. More details are shown in table I. 
Procedures 
Salivary steroid concentrations were measured by RIA after extraction and paper chroma-
tography. The methods used have been previously described in detail (3,6,7,34). Aliquots 
(3 ml) of saliva were incubated with tritiated recovery tracer (± 10,000 dpm each), which 
was used to monitor procedural losses. After extraction of the samples, the dried extracts 
were applied to Whatman no. 1 paper and chromatographed in the appropriate descending 
Bush solvent system: Bush B5 toluene/methanol/water 2:1:1 (v/v) for Cortisol and cortiso-
ne; Bush B3 light petroleum (80-110°) /toluene/methanol/water 333:167:400:100 (v/v) for 
progesterone, testosterone and estradiol; modified Bush A light petroleum (80-
110°)/methanol/water 9:7:4 (v/v) for 17-hydroxyprogesterone and androstenedione. The tri-
tiated hormone areas were located by radioscanning and eluted. The eluates were used for 
recovery counting and RIA. 
The in-house RIA procedures were optimized for the very low concentrations of the ste-
roids in saliva. Dextran-coated charcoal was used for separation of the free and antiserum 
bound fraction. The analytical variables are summarized in table H. 
Statistics 
For the statistical analysis of the results we used Pearson regression analysis and Wilcoxon 
signed rank test. 
Table I. 
Tracers and antisera: HS = hemisuccinate, CET = carboxy-ethyl-thioether, CME = carboxy-methyl-
ether, CMO = carboxy-methyl-oxime, BSA = bovine serum albumin. 
Tracer Specific 
activity 
Immunogen Antiserum 
titer 
[l,2,6,7-3H]-Cortisol 
[1,2-3H]-Cortisone 
[1,2,6,7-3H]-Testosterone 
[ 1,2,6,7-3H]-Progesterone 
83.5 Ci/mmol 
29 Ci/mmol 
102 Ci/mmol 
90 Ci/mmol 
[l,2,6,7-3H]-Hydroxyprogesterone 55 Ci/mmol 
[l,2,6,7-3H]-Androstenedione 85 Ci/mmol 
[l,2,6,7-3H]-Oestradiol 104 Ci/mmol 
Cortisol-21-HS-BSA 22,500 
Cortisone-21-HS-BSA 15,000 
Testosterone-7a-CET-BSA 99,000 
Progesterone-11-HS-BSA 862,000 
ll-Deoxycortisol-21-HS-BSA 336,000 
Androstenedione-19-CME-BSA 7,600 
Oestradiol-6-CMO-BSA 88,000 
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Figure 1. 
Correlation between concentrations of steroid 
hormones in sonified and centrifugea saliva. 
Regression equation and correlation coefficients 
are: 
a. Pogesterone: y = 1.31 x + 0.60; r = 0.9735 
b. Cortisol: y = 0.90 x + 0.50; r = 0.9862 
c. Cortisone: y = 0.96x + 1,78; r = 0.9529 
d. Androstenedione: y = 0.76x + 0.09; r = 0.9830 
e. 17-Hydroxyprogesterone: y = 0.99 x + 0.02; r 
= 0.9729 
f Testosterone: y = 1.14 x + 1.89; r = 0.9827 
g. Oestradiol: y = 1.31 x - 2.50; r = 0.9618. 
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RESULTS 
The results of the determinations of the steroids in whole saliva and in supernatant saliva 
are presented in table 3. Correlations between concentrations in whole saliva and superna-
tant saliva were all highly significant. 
In order to demonstrate differences between the concentrations of the several steroid hor-
mones in whole sailva and supernatant saliva, we calculated for each subject the relative 
increase after sonification of the samples (supernatant saliva = 100 %). These data are 
shown in table 4. 
Table 4. 
Relative difference between whole saliva and supernatant saliva (mean : 
jects, P = probability of Wilcoxon signed rank test, ns = not significant. 
SEM): n = number of sub-
Steroid 
Progesterone 
Cortisol 
Cortisone 
Androstenedione 
Hydroxyprogesterone 
Testosterone 
Oestradiol 
n 
59 
80 
81 
44 
46 
50 
56 
Increase(%) 
36 ± 0.06 
-1 ± 0.01 
10 ± 0.02 
-4 ± 0.03 
17 ± 0.06 
22 ± 0.05 
49 ±0.15 
P 
< 0.0001 
ns 
< 0.0001 
ns 
< 0.0025 
< 0.0001 
0.02 
It appeared that sonification of saliva samples resulted in a statistically significant increase 
in concentrations of the steroid hormones, with the exception of Cortisol and androsten-
edione. Our study group, however, was quite heterogeneous. The subjects were divided in 
a group of pregnant women, non-pregnant women and men. In the pregnant group the 
results for progesterone and estradiol were higher in sonificated than in centrifuged saliva 
(increase 46 ± 10 %, p < 0.0001 and 29 ± 4 %, p < 0.001, respectively), whereas for the 
other steroids there was no significant difference. The values for estradiol in non-pregnant 
female saliva show differences between sonificated and centrifuged samples as similar to 
those observed in pregnancy samples; but this interpretation is preliminary, because despite 
very low sensitivity the levels approximate the detection limit of the assay. In male saliva 
the most striking difference between whole saliva and supernatant saliva was a decrease 
(14 ± 4 %, p < 0.005) in androstenedione values after sonification of saliva, which was not 
observed for female non-pregnant saliva. 
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DISCUSSION 
The present study clearly demonstrates the effect of sample preparation on concentrations 
of steroid hormones measured in saliva. In our study group as a whole, sonification of sali-
va yielded significantly higher levels of steroids than centrifugation, with the exception of 
Cortisol and androstenedione. For these latter hormones the method of sample preparation 
had no influence on the results. Considering the groups of pregnant women, non-pregnant 
women and men separately, the most striking observation was a decrease in androstenedio-
ne concentrations in male saliva after sonification. It is possible that sonificating of the sali-
va samples disperses some unknown substance(s), which interferes in the RIA. It is worth 
mentioning the results of Baxendale et al.(1982) (4), who demonstrated a sex-dependent 
difference in salivary testosterone values when comparing chromatographed and direct 
assays. 
In the non-pregnant and male groups the effect of sample preparation was rather similar to 
that in the study group as a whole. In contrast, in the pregnant group, sonification of saliva 
resulted in higher values only for progesterone and estradiol. The data for progesterone are 
comparable to those of Lequin et al.(1986) (17) and indicate a loss of steroid hormone when 
saliva is centrifuged. It is possible that the pelleted debris of saliva contains most of the 
binding proteins, which are precipitated by the process of freezing and thawing of saliva 
(23), whereas centrifugation leads to a further loss of such proteins (33). 
Our findings indicate that caution is warranted in the interpretation of data from salivary 
steroid hormone determinations. If indeed specific steroid binding proteins are present in 
saliva (31) the question of whether the salivary hormone concentrations reflect the plasma 
free levels has to be re-opened. The question arises as to which of of the analysed mate-
rials, whole saliva or supernatant saliva, gives a real indication of the plasma free level. 
Assuming that the decrease in steroid concentrations in supernantant saliva is caused by the 
removal of specific binding proteins, we tend to believe that the latter is the better candida-
te, despite lower absolute values for the steroid hormones. 
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CHAPTER 5 
Differences between concentrations of salivary Cortisol 
and cortisone and of free Cortisol and cortisone 
in plasma during pregnancy and postpartum 
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Differences between concentrations of salivary 
Cortisol and cortisone and of free Cortisol and 
cortisone in plasma during pregnancy and post-
partum 
P.M.M. MEULENBERG, Dept. Med., Div. Endocrinology and Reproduction, St.Radboud Hospital, Nijmegen, & 
JA. HOFMAN, I. T. S., Nieuweweg 172, 6603 BT Wijchen, The Netherlands. RecievedJune 8, 1989; accepted September, 1989. 
ABSTRACT 
We measured Cortisol and cortisone - both total and free - in plasma and in saliva during 
the course of pregnancy and postpartum. Antepartum and postpartum concentrations and 
morning and afternoon concentrations of both steroids were compared. The mean concen-
trations of Cortisol and cortisone increased towards term and were significantly greater at 
the end of pregnancy than postpartum, except for free Cortisol in plasma in the afternoon. 
The daily rhythm of both steroids was maintained throughout pregnancy and postpartum. 
The correlations between salivary and plasma free concentrations of Cortisol and cortisone 
as well as of the sum of Cortisol + cortisone were highly significant. The mean concentra-
tions of cortisone in saliva accurately reflected both total and free concentrations in plasma. 
For Cortisol, however, the change of the concentrations in saliva, was somewhat different 
from that in plasma. More-over, the mass ratio of plasma free Cortisol to salivary Cortisol 
was about 2, whereas for cortisone the ratio was only about 0.5, probably owing to the con-
version of Cortisol to cortisone by 1 lß-hydroxysteroid dehydrogenase in the salivary gland. 
Furthermore, the passage of Cortisol and cortisone from plasma to saliva should not be 
regarded as simple diffusion, because in the first half of pregnancy the sum of the salivary 
concentrations of Cortisol and cortisone was significantly greater then the sum of their free 
concentrations in plasma. 
INTRODUCTION 
Measurement of Cortisol in saliva is increasingly considered a viable alternative to meas-
urement in plasma. Numerous publications have proven the applicability of salivary Corti-
sol determinations in clinical tests for adrenal activity and in psychological studies as an 
index for stress or endogenous depression (for reviews, see 1,2). The high correlation 
between salivary and plasma free Cortisol is independent of changes in corticosteroid bin-
ding globulin (CBG) concentration (2-4), whereas the relationship between salivary and 
plasma total Cortisol displays nonlinearity. At high concentrations of Cortisol, when CBG 
binding sites become saturated, the concentrations of free Cortisol in plasma, and hence of 
salivary Cortisol, increase proportionally more rapidly than at low concentrations. When 
CBG and Cortisol levels are increased concomitantly, e.g., in pregnancy, concentrations of 
salivary Cortisol appear to be normal (3,5-7), although above-normal concentrations have 
also been reported (8-10). In a longitudinal study, Stahl & Dörner (10) demonstrated that 
mean salivary concentrations of Cortisol gradually increased, exceeding the normal range in 
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the second part of pregnancy. Vining et al.(3), measuring the daily rhythm of salivary Corti-
sol, showed that in the third trimester of pregnancy salivary Cortisol concentrations in mor-
ning samples still overlap normal values, whereas in the afternoon samples the pregnancy 
values are greater. 
Since the earliest work of Shannon et al. (11,12) on 17-hydroxycorticosteroids in saliva, it 
has been known that the concentration of Cortisol in saliva comprises only about 50-60% of 
the concentration of free Cortisol in plasma, because the metabolizing enzyme llß-
hydroxysteroid dehydrogenase (llßHSD; EC 1.1.1.146) in the salivary gland (9), converts 
Cortisol into cortisone. Despite this substantial conversion, the correlation between salivary 
and plasma free Cortisol is maintained in physiological conditions. CBG is also the high-
affinity binding protein for cortisone, but with an association constant about 10 times lower 
than for Cortisol; consequently, there is a much higher proportion of free cortisone than of 
free Cortisol in plasma (13-15). This high free fraction of cortisone in plasma and the sub-
stantial conversion of Cortisol into cortisone in the salivary gland may explain why the 
concentrations of cortisone in saliva exceed those of Cortisol (4,8,16,17), and seem more 
closely related to free Cortisol in plasma than to free cortisone in plasma (4,15,16). 
During pregnancy the placenta is an additional source of plasma cortisone (18). Very little 
is known about the influence of this extra synthesis of cortisone on the ratio of Cortisol to 
cortisone in plasma or saliva. According to Beitins et al.(19), total cortisone is increased in 
plasma during pregnancy, yet the ratio of Cortisol to cortisone is greater than in non-preg-
nant women owing to an relatively greater metabolic clearance of cortisone in pregnancy. 
Others (20,21), however, did not report an increase of total Cortisol over cortisone in plas-
ma. Almost no data are available regarding the ratio of free Cortisol to cortisone in plasma. 
From the results of Dunn et al.(13) one can calculate that the concentration of free cortiso-
ne in plasma is higher in pregnant women then in normally cycling women, in contrast to 
the concentration of free Cortisol in plasma. With regard to salivary concentrations of Corti-
sol and cortisone, Greaves & West (8) showed that in the third trimester of pregnancy sali-
vary Cortisol is twice that of values during nonpregnancy, whereas salivary cortisone is 
increased threefold. The difference in increases of salivary Cortisol and cortisone at the end 
of pregnancy may result from a considerable increase in free cortisone in plasma and(or) a 
higher metabolic conversion rate of Cortisol into cortisone by 1 lßHSD in the salivary gland 
at this time. 
In this study we dealt primarily with the course during pregnancy of total and free concen-
trations in plasma and of salivary Cortisol and cortisone and their inter-relationhips. We 
were further interested in the interaction between Cortisol and cortisone in view of the met-
abolic interconversion during passage of both steroids from blood to saliva. 
MATERIALS AND METHODS 
Subjects and Sampling 
Thirty-six healthy pregnant women, attending the Gynecologic Clinic of the St. Jozef 
Hospital in Doetinchem, volunteered in this study. The study protocol was approved by the 
hospital ethical committee. 
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Matched blood and saliva samples were taken four times during pregnancy - during weeks 
14-19 (period 1), weeks 20-26 (period 2), weeks 27-34 (period 3), and weeks 35-40 (period 
4) - and once at six weeks postpartum (period 5). We collected blood and saliva specimens 
from 19 women at 0900-1000 hours, and from 17 women at 1500-1700 hours. Blood was 
drawn into heparinized tubes and centrifuged (5 min at 1500 X g), and the plasma was sto-
red at -20 °C. Citric acid-stimulated saliva was collected in plastic cups and stored at -20 
°C. Before use , it was thawed and centrifuged (10 min 1500 X g), and the supernatant 
liquid was used for analysis. 
Methods 
Concentrations of Cortisol and cortisone in plasma (total and free) and in saliva were meas-
ured by previously described RIA procedures (4). In short, 0.2 mL of plasma or 0.7 mL of 
saliva was extracted with dichloromethane, the steroids were purified via paper chromato-
graphy in a descending Bush B5 solvent system (toluene/methanol/water, 2/1/1 by vol) 
(22), and the paper eluates were analyzed by RIA. Procedural losses were controlled for by 
including 3H-tracers. 
Steroid specificity was optimized by using the extraction and paper chromatography 
methods. Sensitivity of the RIA was 4 pg/tube, resulting in detection limits of 2300, 53 and 
84 ng/L for plasma total, plasma free, and salivary Cortisol, respectively. The respective 
detection limits for cortisone were 400, 160 and 100 ng/L. The inter- and intra-assay coef-
ficients of variation were <11% and <6%, respectively. 
The concentrations of free Cortisol and cortisone in plasma were determined by equilibrium 
dialysis, followed by the same RIA of Cortisol and cortisone in the dialysate (0.3 mL) (4). 
Inter- and intra-assay coefficients of variation were <7% and <5%, respectively. 
All samples from each study subject were assayed in the same run to eliminate effects of 
interindividual variations. 
Statistics 
For statistical analysis we used Pearson regression analysis, Student's t-test, Bonferoni's t-
test and multiple stepwise regression analysis. 
Results 
Figure 1 shows the temporal changes in concentrations of free and total Cortisol and corti-
sone in plasma and in saliva, expressed as mean ± SEM for each sampling period. 
CONCENTRATIONS IN PLASMA. 
Total Cortisol and cortisone. 
At almost all times the mean concentrations of total Cortisol and cortisone in plasma were 
significantly higher during pregnancy than after parturition, both in the morning and in the 
afternoon. In the latter stages of pregnancy the mean values were twice (Cortisol) or thrice 
(cortisone) the nonpregnant values. At all times the diurnal rhythm was maintained, as 
reflected in the significantly higher values for both Cortisol and cortisone in the morning 
than in the afternoon. 
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Free Cortisol and cortisone. 
By the end of pregnancy, the mean concentration of free Cortisol in plasma had increased 
to about 1.5 times the nonpregnant or postpartum value, both in the morning and in the 
afternoon (Figure 1). However, in the morning samples, free Cortisol was significantly hig-
her than postpartum values only in the second half of pregnancy, whereas in the afternoon 
samples the difference between pregnant and nonpregnant values was not statistically sig-
nificant. 
For free cortisone in plasma increases were comparable with those for total cortisone con-
centrations (about 2.5 times the non-pregnant values) in the morning as well as in the after-
noon. 
The difference between morning and afternoon concentrations of free Cortisol and cortiso-
ne in plasma was even more pronounced (P <0.0001) than for the total Cortisol and cortiso-
ne concentrations, especially in the second half of pregnancy. 
SALIVARY CORTISOL AND CORTISONE. 
At the end of pregnancy the mean concentration of salivary Cortisol had increased to about 
1.5 times the postpartum values in the morning and to about 2.5 times the postpartum valu-
es in the afternoon. 
Mean salivary cortisone concentrations also were significantly increased at the end of preg-
nancy, being double the nonpregnant values in the morning and triple in the afternoon. For 
both salivary Cortisol and cortisone the daily rhythm was evident in all periods. 
PLASMA FREE VS SALIVARY CORTISOL AND CORTISON 
Ratio plasma free over salivary Cortisol. 
The ratios of plasma free over salivary Cortisol for each period in morning and afternoon 
samples are shown in Table 1. The ratio of plasma free over salivary Cortisol in the mor-
ning samples increased in the course of pregnancy. In the first period of pregnancy in the 
morning this ratio was significantly lower than postpartum, but afterwards it increased to 
values comparable to postpartum values. In the afternoon samples the ratio of plasma free 
over salivary Cortisol during pregnancy was significantly lower than postpartum. In the 
non-pregnant period the ratio of plasma free over salivary Cortisol in the afternoon was hig-
her than in the morning. 
The ratio plasma free over salivary cortisone. 
The ratio of plasma free over salivary cortisone, as shown in Table 1, increased towards 
term in the morning samples, and at the end of pregnancy it was significantly higher then 
the postpartum ratio. The afternoon samples showed no statistically significant difference 
between mean ante- and postpartum values. In the non-pregnant period the ratio of free 
plasma to salivary cortisone in the afternoon was higher than in the morning samples. 
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Table 1. 
Ratios of concentrations of Cortisol and cortisone free in plasma to those in saliva 
Period" 
Cortisol 
1 
2 
3 
4 
5 
Cortisone 
1 
2 
3 
4 
5 
Morning samples 
Ratio1 
1.72 + 0.09 
1.78 ±0.08 
2.11 ±0.11 
2.46 ± 0.34 
2.32 ± 0.20 
0.46 ± 0.02 
0.44 ± 0.02 
0.51 ±0.03 
0.59 ± 0.04* 
0.44 ± 0.03 
Afternoon samples 
n 
20 
18 
19 
17 
17 
20 
18 
19 
17 
17 
Ratio* 
1.88 + 0.11= 
2.10 ±0.15= 
2.38 ± 0.29= 
2.28 ±0.11= 
3.53 ± 0.38 
0.50 ± 0.03 
0.47 ± 0.04 
0.60 ± 0.06 
t).61 ± 0.03 
0.63 ± 0.07 
n 
17 
17 
18 
15 
15 
17 
18 
18 
15 
16 
" 1, 14-19 weeks of gestation; 2, 20-24 weeks; 3, 25-34 weeks; 4, 35-40 weeks; 5, six weeks postpar-
tum. * Mean ±SEM.c Significantly different from period 5 (P<0.05, Bonferroni t-test). 
Table 2. 
Cortisol + cortisone concentrations and ratios (Means ± SEM) 
Cortisol + cortisone 
Period n 
Morning samples 
1 20 
2 19 
3 19 
4 15 
5 17 
Afternoon samples 
1 17 
2 17 
3 18 
4 15 
5 16 
Plasma(free) 
»g/L 
11.36 ±0.55 
14.97 ±0.91" 
17.79 ± 0.64" 
21.74 ±1.05" 
11.83 ±1.09 
5.40 ± 0.38 
7.19 ±0.73" 
8.69 ± 0.69" 
11.09 ±0.43" 
6.24 ± 0.79 
Saliva 
»g/L 
14.35 ± 0.78' 
17.29 ±1.26M 
19.02 ± 0.99" 
22.90 ±1.09" 
12.62 ± 0.93 
6.27 ± 0.27= 
8.46 ± 0.65" 
8.90 ± 0.70° 
11.88 ±0.50" 
4.78 ± 0.41 
Plasma(free): 
saliva ratio 
0.81 ±0.03* 
0.86 ± 0.03= 
0.96 ± 0.04 
1.01 ±0.07 
0.98 ± 0.06 
0.85 ± 0.04d* 
0.87 ± 0.06 
1.04 ±0.13 
0.95 ± 0.04 
1.27 ±0.14 
Periods as in Table 1. °bc Significantly different from free plasma concentrations (paired t-test: 
" P<0.0001; " PKO.001; = P<0.01; d significantly different from period 5 (postpartum): P<0.05 
(Bonferroni t-test); ' ratio significantly different from 1.0 (t-test). 
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Table 3. 
Correlation between total plasma, free plasma, and salivary Cortisol and cortisone 
Comparison 
xvsy 
Morning samples 
TFvsFF 
TFvsSF 
FFvsSF 
TEvsFE 
TFvsSE 
FEvsSE 
SEvsFF 
CS vs CF 
TFvsFF 
TFvsSF 
FFvsSF 
TEvsFE 
TEvsSE 
FEvsSE 
SEvsFF 
CS vs CF 
Regression equation 
y = ax + b 
y = 0.020 x + 3.21 
y = 0.011 x + 1.77 
y = 0.432 x+1.00 
y = 0.168 x +0.095 
y = 0.235 x +4.14 
y = 1.295 x + 4.64 
y = 0.88 x + 3.76 
y = 0.97 x +2.31 
y = 0.018 x + 0.69 
y = 0.009 x +0.16 
y = 0.324 x + 0.55 
y = 0.108 x +0.61 
y = 0.150 x +2.23 
y = 1.163 x +2.16 
y = 0.67 x + 3.08 
y = 0.73 x + 2.35 
i" 
0.7552 
0.5513 
0.5949 
0.9059 
0.7312 
0.7450 
0.6958 
0.8017 
0.6947 
0.7319 
0.6965 
0.8474 
0.7829 
0.7714 
0.5705 
0.7548 
n 
93 
93 
93 
92 
91 
91 
91 
91 
85 
83 
83 
86 
85 
85 
85 
84 
Intercept in micrograms per liter. TF, total plasma Cortisol; FF, free plasma Cortisol; SF, salivary 
Cortisol; 
TE, total plasma cortisone; FE, free plasma cortisone; SE, salivary cortisone; CF, free plasma Corti-
sol + cortisone; CS, salivary Cortisol + cortisone; n, number of samples; r = Pearson correlation 
coefficient; " all correlations significant at P < 0.0001. 
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SUM OF CORTISOL AND CORTISONE IN PLASMA AND SALIVA. 
Because of the close interrelationship between Cortisol and cortisone, we were interested to 
know whether the sum of the concentrations of free Cortisol + cortisone in plasma were 
comparable to the sum of the salivary Cortisol + cortisone concentrations. These results are 
shown in Table 2. 
It appeared that the mean concentrations of free Cortisol + cortisone in plasma as well as in 
saliva increased during pregnancy to about twice the postpartum value. In the second half 
of pregnancy the concentration of free Cortisol + cortisone in plasma was virtually comple-
tely matched in saliva. Surprisingly, in the first half of pregnancy, values for Cortisol + cort-
isone in the saliva were greater than could be accounted for by the free concentrations in 
plasma. The ratio of the concentrations of free Cortisol + cortisone to salivary Cortisol + 
cortisone at that time was significantly < 1. 
RELATION BETWEEN FREE CORTISOL AND CORTISONE IN 
PLASMA AND IN SALIVA 
Correlations between plasma free and salivary concentrations. 
The relation between the concentrations of free Cortisol and cortisone in plasma and saliva-
ry Cortisol and cortisone was determined with Pearson regression analysis and the results 
are shown in Table 3. 
There was a statistically significant correlation between free plasma and salivary Cortisol in 
the morning samples as well as in the afternoon samples. An even better correlation was 
found between free plasma and salivary cortisone for both the morning adn the afternoon 
samples. 
The correlation between salivary cortisone and free Cortisol in plasma was somewhat less 
tight at both sampling times. As was to be expected, the closest relation existed between 
the concentrations of free Cortisol + cortisone in plasma and salivary Cortisol + cortisone, 
both in the morning and in the afternoon. 
Stepwise regression analysis. 
To determine the overall dependency of salivary Cortisol on the corresponding plasma total 
and free parameters, we applied multiple stepwise regression analysis (Table 4). This pro-
cedure revealed that salivary Cortisol in morning samples correlated with salivary cortiso-
ne, free Cortisol in plasma, and free cortisone in plasma in an ascending order of partial 
correlation coefficient with P-values < 0.05. In the afternoon samples, salivary Cortisol 
correlated with salivary cortisone, free Cortisol in plasma, free Cortisol + cortisone in plas-
ma, and total Cortisol in plasma. Applying the same procedure for salivary cortisone, it 
appeared that, in morning samples, salivary cortisone correlated with salivary Cortisol and 
free cortisone in plasma. In the afternoon samples the order of the parameters was total 
cortisone in plasma, salivary Cortisol, and free cortisone in plasma. 
It can be concluded that the concentration of Cortisol in saliva depends predominantly on 
salivary cortisone and, surprisingly, less on plasma free Cortisol. The concentration of corti-
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Figure 1. 
Concentrations of plasma total, plasma free and salivary Cortisol (left panel) and cortisone (right 
panel) during the course of pregnancy. 
Mean (± SEM) concentrations during pregnancy and at six weeks postpartum; * = significantly dif-
ferent from postpartum (P < 0.05, Bonferroni t-test). Periods as defined in Materials and Methods. 
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sone in saliva depends strongly on salivary Cortisol in the morning, but more on total corti-
sone in plasma in the afternoon. 
Table 4. 
Multiple stepwise regression analysis. 
Morning samples 
Variables 
SF vs SE 
FF 
FE 
SE vs SF 
FE 
Rp 
0.734 
0.243 
0.199 
0.734 
0.458 
P 
0.0001 
0.0005 
0.005 
0.0001 
0.0001 
Afternoon samples 
Variables 
SF vs SE 
FF 
CF 
TF 
SEvsTE 
SF 
FE 
Rp 
0.731 
0.328 
0.219 
0.149 
0.781 
0.409 
0.123 
P 
0.0001 
0.001 
0.007 
0.02 
0.0001 
0.0001 
0.02 
Abbreviations as in Table 3; Rp = partial correlation coefficient. 
DISCUSSION 
During pregnancy, concentrations of total and free Cortisol and cortisone in plasma increa-
se to two and three times postpartum values, respectively. The daily rhythm, evident for 
Cortisol as well as for cortisone, is maintained until term. Remarkably, the difference 
between morning and afternoon concentrations of total Cortisol in plasma becomes less at 
the end of pregnancy, in contrast to the mean concentrations of free Cortisol in plasma and 
salivary Cortisol. 
Comparing the mean concentrations of free Cortisol and cortisone in plasma at the end of 
pregnancy (period 4) with those postpartum (period 5), it is evident that free cortisone in 
plasma is significantly greater in period 4 in the morning as well as in the afternoon, whe-
reas for Cortisol only in the morning samples a significant difference was found. The mor-
ning values are in line with the view of many authors (23-34) of a hypercortisolism at the 
end of pregnancy at the level of the free concentration in plasma. In the afternoon, howe-
ver, concentrations of free Cortisol in plasma were not significantly different from the 
postpregnant values. This contrasts with data of other investigators (35-39). The results of 
these authors can be critizised on the base of aspecific determinations of total Cortisol in 
plasma or biased measurement of the free fraction of of Cortisol in plasma, leading to erro-
neously high free concentrations in plasma. 
In saliva the picture is different for Cortisol and cortisone. Cortisone in saliva is a true 
reflection of the plasma free concentration, but Cortisol is not, because the mean concentra-
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tions of Cortisol in saliva show a plateau in the second part of pregnancy, whereas the con-
centrations of free Cortisol in plasma keep increasing. Nevertheless, the mean concentrations 
of Cortisol in saliva were significantly greater in pregnancy than postpartum values, confir-
ming the results of other investigators (6,8-10). 
The passage of unconjugated steroids has - until recently - always been regarded as a simp-
le diffusion process through the salivary gland. Chu & Ekins (40), however, reported the 
presence of CBG in saliva and concluded that salivary steroid concentrations are not identi-
cal to their corresponding free concentrations in plasma. With regard to the concentration 
of Cortisol in saliva the relation to free Cortisol in plasma is complicated by the conversion 
of Cortisol into cortisone in the salivary gland. The presence of the enzyme 1 lß-HSD in the 
salivary gland was first noted by Katz and Shannon (9), whereas no activity could be 
demonstrated in liquid saliva (8,9,41), confirmed by our onw experiments (personal obser-
vations). 
To determine what proportion of free Cortisol in plasma appears in saliva, we calculated the 
ratio of the concentrations of free Cortisol in plasma to salivary Cortisol in each period (Table 
1). For nonpregnant women this ratio was 2.32 ± 0.20 in the morning and 3.53 ± 0.38 in 
the afternoon, indicating that in the morning relatively more free Cortisol in plasma reaches 
the saliva than in the afternoon, which might be a result of less conversion of Cortisol into 
cortisone. In the first period of pregnancy this ratio was decreased to 1.72 ± 0.09 and 1.88 
±0.11, respectively, being statistically different from postpartum (P < 0.05, Bonferroni t-
test). From these data we conclude that, at least in the first half of pregnancy, Cortisol in 
saliva constitutes a greater part of the corresponding free concentration in plasma than that 
postpartum. During the latter stages of pregnancy this ratio increased to postpartum values 
in the morning, whereas in the afternoon the ratio remained below postpartum values. 
The picture is quite different for cortisone. The ratio of the concentrations of free cortisone 
in plasma to salivary cortisone in morning samples increased during pregnancy, the ratio 
being significantly higher than the postpartum ratio in period 4. This implies that at the end 
of pregnancy there is relatively less cortisone in saliva than might be expected from the 
free cortisone concentration in plasma. In the afternoon there was no statistically signi-
ficant difference in the ratio free plasma to salivary cortisone between all periods. 
In our study we also calculated the combined concentrations of Cortisol + cortisone free in 
plasma and in saliva. As shown in Table 2, in the first half of pregnancy the mean concen-
trations of Cortisol + cortisone in saliva were significantly higher than free Cortisol + corti-
sone in plasma (ratio < 1.0), indicating that more Cortisol + cortisone reaches the saliva 
than might be expected from their combined free concentrations in plasma. Relating these 
data to the ratios of plasma free over salivary Cortisol or cortisone, as discussed above, our 
conclusion is that in the first half of pregnancy the increased concentration of Cortisol + 
cortisone in saliva compared with their free concentrations in plasma is caused predo-
minantly by Cortisol. 
Note the difference between the concentrations of free Cortisol + cortisone in plasma and 
salivary Cortisol + cortisone in the postpartum afternoon samples. Remarkably, less Cortisol 
+ cortisone was measured in saliva then could be expected from their corresponding free 
concentrations in plasma. However, this difference did not reach statistical significance (P 
< 0.10, Student's t-test) and conclusive data await further research. 
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Summarizing our results, we conclude that pregnancy leads to a hypercortisolism and a 
hypercortisonism at the level of the free concentrations in plasma, especially in the second 
half of gestation, which is reflected in saliva. It should be mentioned, however, that when 
one is measuring corticosteroids in plasma or in saliva it is very important to take into 
account the daily rhythm of these steroids. When free Cortisol is measured in plasma only 
in the afternoon, a hypercortisolism is no longer demonstrable. 
The correlation between of concentrations of Cortisol and cortisone free in plasma and in 
saliva was highly significant. The same holds true for the correlation between free plasma 
and salivary concentrations of Cortisol + cortisone. An also highly significant, but somew-
hat less tight, correlation exists between free Cortisol in plasma and salivary cortisone. 
Despite an excellent corelation between free Cortisol in plasma and in saliva, however, the 
picture of the courses of the mean concentrations during pregnancy and postpartum shows 
some discrepancies. 
The passage of both steroid from plasma to saliva is not a simple diffusion. Apart from the 
conversion of Cortisol into cortisone by llß-HSD in the salivary gland, which is clearly 
demonstrated in our study, it appears that in the first half of pregnancy the sum of Cortisol 
+ cortisone recovered in saliva is significantly greater than could be expected from their 
free concentrations in plasma. This observation could be explained be a concomitant secre-
tion of CBG and/or albumin in saliva (40). More research is needed to elucidate the mecha-
nisms involved in the passage of Cortisol and cortisone from plasma to saliva and it may be 
interesting to implicate the influence of corticosteroids on salivary blood flow (42) and the 
possibility of product inhibition at the level of llß-HSD metabolism (43). 
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on the daily rhythm of Cortisol and cortisone 
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The effect of oral contraceptive use and preg-
nancy on the daily rhythm of Cortisol and corti-
sone 
P.M.M. MEULENBERG, Dept. Med., Div. Endocrinology and Reproduction, St.Radboud Hospital, Nijmegen, & 
J.A. HOFMAN, Immuno Technology Service, Nieuweweg 172, 6603 BT Wijchen, The Netherlands. 
SUMMARY 
The effect of oral contraceptives and of pregnancy on the daily rhythm of Cortisol, and its 
metabolite cortisone in plasma and saliva has been investigated. In both conditions the total 
plasma Cortisol levels were raised to the same extent, the mean values in saliva in the oral 
contraceptive users being intermediate between those in pregnancy and in the controls, par-
ticularly in the morning. Salivary cortisone levels were more related to salivary Cortisol 
than to total plasma cortisone which exhibited a rather flat daily rhythm. There was a shift 
in peak values for salivary Cortisol and cortisone towards late morning: this may be due to 
a delay in the daily activation of the hypothalamic-pituitary-adrenal-axis in these subjects. 
KEYWORDS: 
DIURNAL RHYTHM, SALIVA, CORTISOL, CORTISONE, PREGNANCY, ORAL CONTRACEPTIVES. 
INTRODUCTION 
The stimulatory influence of estrogens on the synthesis of corticosteroid-binding globulin 
(CBG) and the related increases in total plasma Cortisol during oral contraceptive (OC) usa-
ge and in pregnancy have been described [1-6]. The biologically active fraction of Cortisol 
in blood is located in the non-protein-bound moiety of plasma Cortisol. While the daily 
rhythm in free plasma Cortisol in pregnancy and OC users is maintained it is questionable 
whether plasma free Cortisol is increased during OC usage or in pregnancy [7-10]. The dis-
crepancies in reported data on free plasma Cortisol concentrations are related to the diffe-
rent methods of analysis: these are time consuming and sensitive to experimental condi-
tions such as temperature and dilution [11]. 
The concentrations of Cortisol in saliva are closely related to the free concentrations in plas-
ma and the salivary assay is regarded as an excellent substitute for the free plasma Cortisol 
concentration [12-14]. Salivary Cortisol also exhibits a daily rhythm similar to total plasma 
and free plasma Cortisol [15]. Vining et al [16] compared the daily rhythm of Cortisol in the 
saliva of third trimester pregnant women and non-pregnant women. It was concluded that 
salivary Cortisol concentrations at the end of pregnancy were raised above the normal during 
the day, showing a significant difference in the afternoons. 
The enzyme, llß-hydroxy-steroid dehydrogenase (11HSD), which is present in the salivary 
glands converts approximately 50 % of Cortisol to cortisone during its passage from plasma 
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into saliva. Thus, the concentrations of salivary cortisone are probably related more to free 
plasma Cortisol than to free plasma cortisone [17]. The daily rhythm of salivary cortisone, 
especially during OC usage or in pregnancy has not been reported hitherto. This paucity of 
data prompted us to investigate matched samples of plasma and saliva obtained from women 
taking oral contraceptives, pregnant women, and a group of controls. 
MATERIALS AND METHODS 
Subjects 
Twenty six healthy individuals volunteered for the study: 10 were pregnant women, 11 were 
women using low-estrogen OC's and 12 were non-pregnant women, not using OC, who 
served as the control group. The women from the pregnancy group who returned postpar-
tum were subsequently classified as controls. The age of the women ranged from 20 to 48 
years. 
The oral contraceptives used were Stediril, microgynon-30, trinordiol and trigynon. 
Sampling protocol 
All of the volunteers provided citric-acid stimulated saliva samples during a whole day 
from approx. 05.00 a.m. until midnight. Portions (5 mL) of saliva were collected in plastic 
cups every 30 min. in the early morning and then at intervals of one or two hours. They 
were then stored at -20°C until analysed. The saliva samples were thawed, centrifuged (10 
min. 1500 X g) and the supernatant used for the assay. 
Matched blood from 10 women (2 controls, 3 OC-users and 5 pregnant) was also sampled. 
An indwelling catheter was used to draw (5 mL) blood into heparinized vacutainer tubes 
between 07.00 and 15.00 h. The blood was centifuged (5 min. at 1500 x g) and the plasma 
stored at -20°C prior to analysis. Four pregnant women returned two or three times during 
their pregnancies and then post partum. 
Ten members of the pregnancy group provided salivary samples 2 to 3 times during their 
pregnancy and from 4 of these we also obtained matched plasma samples. 
The individuals in the OC-users group provided saliva, and where possible plasma samp-
les, at the end of the "on-pill" period and at the end of the "off-pill" week. 
METHODS 
Salivary and total plasma Cortisol and cortisone concentrations were measured by RIA, 
after previous extraction and paper chomatography as described earlier [17]. Plasma free 
Cortisol was determined using equilibrium dialysis (1:1) followed by the same RIA of Cort-
isol in the dialysate [17]. 
DATA ANALYSIS 
Data processing was performed using SAS software (SAS Institute, Carey, NC). The profi-
le of the daily variation in hormone concentrations was characterized by several parame-
ters. Each daily rhythm consisted of about 10 consecutive samples, which provided a peak 
level and a matched peak time. The area-under-the-curve (AUC) for each daily profile was 
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calculated using a trapezoidal method (addition of all trapezoidum areas between sampling 
points) and a standardized AUC (S-AUC), i.e. the AUC per hour. Theoretical peak levels 
and matched peak times via parabol calculation were also computed since the concentra-
tions of both hormones changed rapidly during the mornings, and because sampling-time 
intervals were more then 20 min. apart. Group comparison of the data was performed with 
the ANOVA t-test. 
Table I. 
Rhythm parameters of salivary and plasma Cortisol and cortisone. 
CONTROLS 
mean ± sem 
a) Salivary data via the 
SFx 16.4 ±1.0 
SFt 7.10 + 0.26 
SFs 5.0 ± 0.5 
SEx 32.6 ± 2.4 
SEt 7.26 ± 0.24 
SEs 14.1 ± 1.1 
n 
OC-GROUP 
mean ± sem 
trapezoidal method: 
12 
12 
12 
12 
12 
12 
b) salivary data via the parabol method: 
SFx-c 17.8 ± 1.5 
SFt-c 7.19 ±0.24 
SEx-c 33.6 ± 2.9 
SEt-c 7.32 ± 0.20 
9 
9 
10 
10 
c) plasma data via the trapezoidal method 
TFx 482 ± 62 
TFt 7.90 ± 0.37 
TFs 261 ± 29 
TEx 57.1 ±4.4 
TEt 7.67 ± 0.30 
TEs 34.1 ±5.8 
4 
4 
4 
4 
4 
4 
20.8 ± 1.3 
7.59 ±0.17 
6.4 ± 0.7 
38.5 ±2.1 
7.90 ± 0.20 
17.1 ±1.3 
20.8 ± 1.4 
7.72 ±0.15 
38.2 ±1.8 
7.80 ±0.15 
1089 ± 146' 
8.28 ± 0.70 
679 ± 95' 
84.9 ± 8.3 
10.12 ±0.75' 
63.2 ± 6.7 
n 
24 
24 
24 
24 
24 
24 
21 
21 
24 
24 
5 
5 
5 
5 
5 
5 
PREGNANCY GROUP 
mean ± sem 
23.0 ±1.4' 
7.92 ± 0.20' 
8.2 ± 0.5"-" 
53.0 ± 3.2'b 
7.97 ±0.21' 
26.5±1.6''b 
23.7 ± 1.6' 
8.17 ±0.24' 
56.5 ± 3.8'" 
8.32 ± 0.23*-" 
1006 ± 103' 
7.89 ± 0.35 
703 ± 66' 
116.2 ± 12.8» 
9.65 ± 0.47' 
91.5 ±9.2' 
n 
28 
28 
28 
28 
28 
28 
23 
24 
22 
22 
n, number of subjects; SFx, salivary concentration of Cortisol (nM/l); SFt, matched peak time of sali-
vary Cortisol (h); SFs, S-AUC of salivary Cortisol (nM/l per h); SEx, salivary concentration of corti-
sone (nM/l); SEt, matched peak time of salivary cortisone (h); SEs, S-AUC of salivary cortisone (nM/l 
per h); SFx-c, parabol calculated concentration of salivary Cortisol; SFt-c, calculated matched peak 
time; SEx-c, calculated concentration of salivary cortisone; SEt-c, matched peak time; TFx, concen-
tration of plasma total Cortisol (nM/l); TFt = matched peak time of plasma total Cortisol; TFs, S-
AUC of plasma total Cortisol (nM/l per h); TEx, concentration of plasma total cortisone (nMÂ); TEt, 
matched peak time of plasma total cortisone; TEs, S-AUC of plasma total cortisone (nM/l per 
h). " Significantly different from controls.b Significantly different from OC-group (t-test). Real clock 
times in hr:min are derived from the peak time decimal x 0.6. 
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RESULTS 
Shift in daily rhythm characteristics of salivary and plasma Cortisol and cortisone in 
normal women, women taking oral contraceptives and pregnant women 
The concentrations of salivary and total plasma Cortisol and cortisone in the three groups 
are shown in Fig. 1. Elevated levels of salivary Cortisol and cortisone were observed in 
pregnancy and OC-usage (P < 0.0001, ANOVA) and the peak time of each hormone was 
shifted towards later in the morning. 
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Figure 1. 
Daily rhythm of salivary and plasma total Cortisol and cortisone. Mean concentrations of (A) salivary 
(ng/dl) and (B) plasma total (ug/1) Cortisol and cortisone; (X—X) control group, (A—A) OC group, 
(T—T) pregnant group. 
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Figure 1, continued 
Salivary and plasma Cortisol and cortisone concentrations in control women, women 
using oral contraceptives and pregnant women 
The mean (± SEM) peak level, matched peak time, AUC and S-AUC calculated from the 
daily profiles of salivary and plasma Cortisol and cortisone indicated that each of these indi-
ces increased significantly during pregnancy (Table Ia-c). The values for these indices in 
the OC-users group were intermediate between those of the control and the pregnancy 
groups. 
It is evident (Table la) that increases in the concentrations of salivary Cortisol and cortisone 
are accompanied by a delay in peak times. Additional supporting evidence was provided 
by parabol calculation of peak concentrations and matched peak times (Table lb). 
Analysis of the data from plasma demonstrated only slight differences between the OC-
users and the pregnancy group, the substantial increase in mean total plasma concentra-
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Figure 2. 
Daily rhythm in salivary Cortisol and cortisone in the course of pregnancy. 
Concentrations of salivary Cortisol and cortisone (ng/dl) in the first (T—T), second 
(X—X) and third ( O — O) trimester of pregnancy and 2 months postpartum (A—A). 
tions and S-AUC of Cortisol being confirmed (Table Ic). The absence of any marked delay 
in the plasma Cortisol peak times compared to the significant delay of the corresponding 
cortisone value was noteworthy. It was also shown that an increase in total plasma concen-
tration and S-AUC of cortisone occurred only during pregnancy. 
Rhythm parameters of salivary and plasma Cortisol and cortisone in pregnancy 
The Cortisol and cortisone data, divided in values from the first half and the second halves 
of pregnancy, are shown in Table II. The peak concentrations of salivary and total plasma 
cortisone, and the matched S-AUC, were significantly higher in the second half of preg-
nancy. Insignificant statistical differences were detected for the Cortisol parameters. 
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Figure 3. 
Relation between salivary and plasma free Cortisol and cortisone in one woman. 
Concentrations (ng/dl) of salivary (A—A) and plasma free (T—T) Cortisol and cortisone from one 
subject in the third trimester of pregnancy. 
Rhythm parameters of salivary and plasma Cortisol and cortisone levels in women using 
oral contraceptives 
Insignificant differences were found between the "on-pill" and the "off-pill" sampling days, 
although the peak time for salivary Cortisol and cortisone showed a tendency to be delayed 
at the end of the "on-pill" cycle (7.89 ± 0.20 h vs 7.39 ± 0.21 h for salivary Cortisol and 
7.99 ± 0.18 h vs 7.48 ± 0.25 h for salivary cortisone). 
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Salivary versus plasma free Cortisol and cortisone in pregnant women 
Salivary Cortisol is thought to be derived preponderantly from plasma free Cortisol. The 
daily rhythm in salivary Cortisol and in plasma free Cortisol was compared in a few indivi-
duals. The curves almost parallelled each other, although the concentrations of salivary 
Cortisol were approximately half the free plasma Cortisol. 
In contrast, there was a poor relationship between salivary and free plasma cortisone, at 
least at the end of pregnancy, when cortisone in plasma was high. The daily rhythm of sali-
vary cortisone was then comparable to that of salivary and free plasma Cortisol, whereas 
free plasma cortisone, after an initial morning peak did not decrease until the end of the 
sampling time (14.00 h). 
Table II. 
Rhythm parameters of salivary and plasma Cortisol and cortisone in pregnancy. 
Pregnancy First half Second half 
Mean ± SEM n Mean ± SEM n 
a) Salivary data via the trapezoidal method: 
SFx 22.5 ±2.5 11 23.3 ±1.7 16 
SFt 7.99 ±0.35 12 7.86 ±0.25 16 
SFs 7.4 ±1.1 12 8.7 ±0.4 16 
SEx 45.1 ±4.8 12 58.7 ± 3.8' 16 
SEt 7.93 ±0.32 12 8.01 ±0.28 16 
SEs 20.8 ± 1.9 12 30.8 ± 1.9" 16 
b) salivary data via the parabol method: 
SFx-c 23.3 ±3.4 7 23.9 ±1.8 16 
SFt-c 8.62 ±0.44 8 7.94 ±0.27 16 
SEx-c 47.0 ±6.7 8 61.9 ±4.1" 14 
SEt-c 8.47 ±0.40 8 8.23 ±0.29 14 
c) plasma data via the trapezoidal method: 
TFx 874 ±182 3 1056 ±126 8 
TFt 7.56 ±0.39 3 8.02 ±0.46 8 
TFs 591 ±118 3 745 ±78 8 
TEx 76.3 ±5.8 3 131.2 ±13.9' 8 
TEt 8.75 ±0.89 3 9.99 ±0.53 8 
TEs 60.2 ±4.4 3 103.5 ±9.4" 8 
For parameter explanation see Table I; n, number of observations. " Significantly different from valu-
es in the first half of pregnancy. 
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DISCUSSION 
The present study demonstrates clearly the effects of OC-usage or pregnancy on the daily 
rhythm of salivary Cortisol and cortisone leading to an increase in peak levels and a delay 
in peak time. In particular, a shift in peak time from ca. 07.00 h. under non-pregnant condi-
tions to ca. 08.00 h. during pregnancy was found to occur. This observed time shift was 
supported by comparing earlier data of total plasma Cortisol during pregnancy and normal 
values. Analysis of these data indicated a similar shift in the time of appearance of the maxi-
mal total plasma concentration of Cortisol towards later in the morning. This observation 
had not been discussed earlier [18-20]. 
There were no significant statistical differences in the mean plasma concentrations of Corti-
sol and cortisone between the OC-users and the pregnancy group. The salivary rhythm para-
meters in the OC-users group were however intermediate between the other two groups in 
the morning, but no deviation from the normal group was observed in the evenings. 
In the current study samples were obtained more than once from the pregnant women during 
the gestation and postpartum period. A steady shift in the peak time to later in the morning 
during gestation was observed when the individual daily rhythms of Cortisol and cortisone 
were compared (Fig. 2). They returned to early morning in the postpartum period. The Cort-
isol and cortisone parameters (Table II) obtained during the first half of pregnancy were 
then compared with those of the second half and with the control. These showed that an 
increase in peak time and concentrations occurred mainly during the first half. This obser-
vation supported earlier results [21,22] which suggested a sharp increase in plasma total 
Cortisol and CBG during the first half of pregnancy, followed by subsequent levelling. The 
largest deviation from normal cortisone values were noted during the second half. 
The daily rhythm of Cortisol and cortisone at the end of the "on-pill" and "off-pill" periods 
in the OC-users group were then compared. No significant differences in the measured 
parameters were observed on these days, although the peak times for salivary and total plas-
ma Cortisol and cortisone increased slightly at the end of the "on-pill" period. The individu-
al curves of salivary Cortisol and cortisone showed a peak-time shift (ca. 30 minutes) at the 
end of the "on-pill" period, although there were no significant differences in the concentra-
tions of either hormone. 
The results of earlier work [23,24] could help explain the shifts in peak time of the daily 
rhythm of Cortisol and cortisone during OC usage and pregnancy observed in the current 
study. These earlier studies reported that the increased synthesis of CBG, and concomitant 
increase in total plasma Cortisol during OC usage and pregnancy was estrogen induced. 
This resulted in a lowered metabolic clearance rate and a higher tl/2 for the metabolism of 
Cortisol. CBG-bound Cortisol appeared to have some buffer function in the plasma. 
Stimulation of HPAA feedback is initiated when the concentration of free plasma Cortisol 
decreases below a minimum value, which is reached some hours prior to morning awake-
ning under normal conditions. There is a delay in reaching this minimum if the buffer capa-
city of CBG-cortisol is large. A corresponding delay in the activition of HPAA then ensues. 
A delay in the stimulation of Cortisol synthesis by the adrenal glands during pregnancy has 
also been reported [25]. The daily rhythms of cortisone, a metabolite of Cortisol, will like-
wise parallel this shift. 
96 
The effect of oral contraceptive use and pregnancy on the daily rhythm of Cortisol and cortisone 
An elevated level of free plasma Cortisol in the two study groups was observed in the mor-
nings when the daily concentration rhythms were compared with the control (P < 0.05, 
ANOVA, n=5; data not included). These returned to the mean normal values during the 
afternoon. A normal level of free plasma cortisone was observed for OC users, whereas an 
increased level during pregnancy was maintained throughout the day. The measured data 
also indicated that free plasma Cortisol levels (P > 0.05) during pregnancy were not above 
normal in the afternoons. The levels in saliva were however raised (P < 0.001) both in the 
afternoons and evenings. The increased afternoon levels could be explained by the increa-
sed concentrations of free plasma cortisone. This would lead to product inhibition in the 
conversion of Cortisol to cortisone during its passage from plasma to saliva. The possibility 
of product inhibition by llßHSD by cortisone has been reported [26]. 
It would now be of interest to extend the current study to include salivary, total plasma and 
free plasma cortisol-cortisone measurements over a 24-h period in OC-users and pregnant 
women during gestation. This would determine whether in the night free plasma concentra-
tions of Cortisol and cortisone were normal and to what extent the raised total plasma and/or 
free plasma Cortisol concentrations contribute to salivary Cortisol levels. 
It may be concluded from the results described here that there is a shift in the peak time of 
diurnal rhythms of salivary Cortisol and cortisone towards later in the morning in condi-
tions where CBG or total plasma Cortisol are raised non-patholagically, i.e. OC usage or 
pregnancy. This process proceeds steadily during pregnancy fron the first trimester until 
term. 
The concentrations of salivary and total plasma Cortisol and cortisone are raised signifi-
cantly during pregnancy. This results in increased S-AUC values for these two hormones in 
both plasma and saliva, whereas during OC usage only the total plasma concentrations of 
Cortisol and the matched S-AUC values are increased significantly. A discrepancy was 
shown to exist between the daily rhythms of salivary and free plasma Cortisol. The values 
for free plasma Cortisol were normal during the afternoon but were elevated in saliva. 
The observed time shift in the daily rhythms of Cortisol and cortisone under conditions of 
raised CBG concentrations suggests that single time point comparisons of the concentra-
tion of these two hormones should be interpreted with caution. 
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The relation between Cortisol and cortisone in 
saliva and in plasma in various hormonal condi-
tions 
INTRODUCTION 
The possibility to measure Cortisol in saliva as an indicator of stress has been known since 
the work of Shannon and coworkers [1-13]. Renewed interest in saliva as biological medi-
um for clinical chemical purposes appeared with the development of more accurate and 
especially more sensitive methods, e.g. the immunoassay. Indications that salivary Cortisol 
might replace the laborious measurement of plasma free Cortisol led to a review of earlier 
data concerning levels of plasma free and salivary Cortisol in several conditions [14,15]. 
It is expected that when total plasma Cortisol is increased concomittant with Corticosteroid 
Binding Globulin (CBG), the plasma free level of Cortisol, as a result of the negative feed-
back system of the Hypothalamo Pituitary Adrenal Axis (HPAA), will be in the normal ran-
ge and symptoms of hypercortisolism will not be exhibited [16,17]. This increase in total 
Cortisol together with CBG is found in pregnant women and women who take estrogen-
containing oral contraceptives (OC's) [18-25]. Earlier data, however, are contradicting at 
the point of the level of plasma free Cortisol in these conditions [26-52]. Several factors 
may underlie these contradicting results. They include methodological and physiological 
factors [53-63]. The main factors leading to erroneous and/or deviating results are dilution 
of sample without proper correction, and disregard of the daily rhythm of Cortisol, res-
pectively. 
If salivary Cortisol is to replace plasma free Cortisol as a measure of adrenal activity certain 
conditions have to be met: 
1) free diffusion from plasma to saliva; 
2) independent on flow rate or diffusion rate; 
3) no passage of binding protein; 
4) no influence of metabolic reactions. 
There is general agreement that the first two conditions are met. With regard to binding 
proteins, in this respect mainly CBG, its presence has been demonstrated in saliva but its 
origin is still a matter of controverse [64,65]. 
The activity of the enzyme llßHSD in the salivary gland is generally accepted; about half 
of plasma free Cortisol is converted into cortisone, a presumed inactive metabolite [65-67]. 
llßHSD is present in virtually all tissues and it has a definite role in mineralocorticoid tar-
get organs and in placenta [68-76]. About its function in the salivary gland nothing is 
known, but it is said that its activity has no influence on the applicability of salivary Corti-
sol [77]. In most studies salivary Cortisol is measured with RIA, whether directly or after 
an extraction step, which is more or less aspecific due to cross-reacting compounds, inclu-
ding cortisone. Ferguson [78] already expressed his amazement about the fact that the pro-
portionality of plasma free and salivary Cortisol is maintained despite conversion. 
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This study was designed to investigate the relation between Cortisol in saliva and free in 
plasma. Special care was taken to use the best available methods. Besides, to avoid any inf-
luence of the daily rhythm of corticosteroids, all samples were taken at about 9.00 h a.m. 
Another feature of the study was to investigate whether in conditions of raised CBG, i.e. 
during pregnancy or usage of OC's, levels of free Cortisol in plasma indicate a state of 
hypercorticism and, if so, whether this is reflected in salivary Cortisol levels. A further featu-
re of the study was to investigate the influence of changed hormonal status on the activity 
of 1 lßHSD in the salivary gland. Finally, another aspect of the study was to get more insight 
in the mechanism of passage of Cortisol (and cortisone) from plasma to saliva, especially 
regarding the influence of llßHSD on the relation between plasma free and salivary con-
centrations. 
MATERIALS AND METHODS 
Subjects 
Five groups of women were included in the study: 
a) a control group (N-groep): 14 normal, healthy women not taking any medication; 
b) a pregnant group (P-group): 15 pregnant women at the end of pregnancy; 
c) a postpartum group (PP-groep): 18 women 6 weeks after delivery; 
d) an OC group (M-group): 23 women taking Marvelon, (30 ug ethinyl estradiol + 150 ug 
desogestrel) for more than 3 months; 
e) another OC group (S-group): 26 women taking Stediril, (30 ug ethinyl estradiol +150 
ug levonorgestrel) for more than 3 months). 
All women were 18-45 years. 
Sampling 
Matched samples of blood and saliva werd collected at 9.00 - 9.30 h a.m. For the N-group 
and the OC-groups on day 18 of the menstrual and pill cycle, respectively. For the P-group 
at week 38 - 40 and for the PP-group at 6 weeks postpartum. 
Blood was drawn into heparinized tubes, centrifuged and the plasma was stored at -20°C 
until analysis. Citric acid stimulated saliva was collected into plastic cups and frozen 
at -20°C. Before analysis these were thawed and centrifuged and the clear supernatant was 
used for the determinations. 
CBG 
Plasma CBG concentrations were determined with a CBG RIA kit purchased from 
Medgenix (Brussels, Belgium). 
Plasma total and salivary Cortisol and cortisone 
Concentrations of plasma total and salivary Cortisol and cortisone were measured as descri-
bed earlier [79]. In short, to 0,2 ml plasma or 0,5-0,7 ml saliva were added tritium labeled 
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Cortisol and cortisone as recovery tracer. The samples were extracted with methylenechlori-
de and paper chromatographed in a descending Bush B5 system. Individual corticosteroids 
were analyzed with in-house RIA. 
Plasma free Cortisol and cortisone 
Concentrations of plasma free Cortisol and cortisone were determined with equilibrium dia-
lysis followed by extraction, paper chromatography and RIA as described above. Details 
of this method are described earlier [79]. 
Statistics 
Statistical evaluation of the results was performed with SAS Software (SAS Institute Inc., 
Cary, NC) 
RESULTS 
Comparison of groups 
Mean values 
For all five study groups the mean values (± S.D.) for each parameter were calculated. The 
results are shown in Table 1. Additionally, sum parameters for plasma free and salivary 
Cortisol + cortisone were calculated for each subject and the mean values are included in 
Table 1. 
It appeared that in the P-group all parameters were increased compared to the N-group. 
Salivary Cortisol, however, did not reach statistical significance when calculated with ANOVA 
Bonferoni t-test. However, when applying Student's t-test, mean values were significantly 
different. 
The PP-group was statistically comparable to the N-group. Mean free Cortisol was elevated 
but individual values were in a broad range of levels. Again when using Student's t-test, 
mean plasma free Cortisol was significantly elevated above normal in the PP-group. Both 
the M- and the S-group showed mean values between the N- and the P-group. CBG and 
Cortisol levels approached pregnant values, but cortisone levels were nearer to the normal 
range. 
Hypercortisolism 
Plasma free Cortisol is regarded to be the best parameter for the assessment of a condition 
of hypercortisolism. In normal condition plasma free Cortisol ranges from 332 - 842 ng/dl. 
Mean values were significantly increased in the P-, the M- and the S-group. Individual valu-
es ranged from 905 - 1586 ng/dl, 756 - 1787 ng/dl and 366 -1366 ng/dl, respectively. From 
these results if must be concluded that pregnancy and OC-usage lead to a state of hyper-
cortisolism, although some overlap with normal values exists in OC-using women. 
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The postpartum group was sampled at six weeks after delivery, at which time hormonal 
status is generally believed to be returned to normal. With regard to the plasma free Cortisol 
individual values ranged from 203 - 1659 ng/dl and eight out of eighteen values were abo-
ve the normal maximum. This contradicts the general assumption mentioned above. 
Salivary Cortisol is considered to give a reflection of plasma free levels. The normal range 
was from 173 - 405 ng/dl. Comparing these values with those of the other study groups it 
appeared that in the pregnant group despite a raised mean value and the finding that only 
three out of 15 samples were within the normal range, statistically there was no significant 
difference between these two groups when calculated with ANOVA Bonferoni t-test, but 
when using the Student's t-test salivary Cortisol is significantly elevated in pregnancy. 
In the postpartum group six out of 18 samples were above the normal range. Salivary Corti-
sol in both OC groups was significantly elevated; in the M-group only two samples were in 
the normal range and in the S-group only one sample. 
Plasma free and salivary cortisone 
Plasma free cortisone was significantly elevated above normal only in the pregnant group, 
a finding which was also true for salivary cortisone. Comparing both OC groups it appe-
ared that mean salivary cortisone was significantly lower in the S-group than in the M-
group. 
Sum of Cortisol + cortisone 
The passage of corticosteroids from plasma to saliva is considered to proceed via a diffu-
sion process. Metabolism in the salivary gland converts Cortisol into cortisone. Hence, it 
was expected that levels of plasma free Cortisol + cortisone (FFE) would not be different 
from salivary Cortisol + cortisone (SFE). However, as must be concluded from the results 
in Table 1, SFE was significantly higher than FFE, except in the postpartum group. This 
contradicts a simple diffusion process. 
Relations between several parameters 
To determine the relations between the various parameters initially normal regression ana-
lysis was performed. 
CBG and Cortisol 
Plasma total Cortisol is expected to increase in concordance with CBG. A statistically signi-
ficant correlation (p<0.05) between these two parameters was only found in the Marvelon 
and the postpartum groups, but did not exist in the other study groups. Any correlation 
between CBG and the other parameters measured could not be demonstrated. 
Plasma free and salivary Cortisol 
Salivary Cortisol was significantly correlated with plasma free Cortisol in all study groups. 
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Plasma free and salivary cortisone 
Salivary cortisone correlated significantly with plasma free cortisone in normal conditions 
and during OC usage, but not during pregnancy and at 6 weeks postpartum. 
Plasma free and salivary Cortisol + cortisone 
The sumparameter for Cortisol + cortisone showed significant correlations between plasma 
free and salivary concentrations in all study groups. 
Percentage free and salivary Cortisol and cortisone 
Cortisol in plasma is for the greater part bound to CBG. As shown in Table 3, the fraction 
of free Cortisol (%FF) accounts for about 4% of the total concentration in plasma in normal 
conditions and postpartum. This fraction is significantly lower at the end of pregnancy, due 
to the increase of CBG. In the OC groups the percentage free Cortisol was even more decre-
ased: 2,5%. The same holds true for the free fraction of cortisone (%FE) and also for the 
combined fractions of free Cortisol + cortisone (%FFE). 
The fraction of Cortisol in saliva relative to the plasma total concentration is about half that 
of the plasma free fraction, due to metabolic conversion. This conversion seems to be 
greater in both OC-groups. This is reflected in the fraction of salivary cortisone relative to 
plasma total cortisone (%FE). The mean %FE in both OC-groups is more than 3 times the 
%FE, whereas in the other study groups this factor is slightly higher than 2. 
The higher binding of corticosteroids in conditions of increased CBG levels is apparent 
when comparing the values of the fractions of plasma free Cortisol + cortisone and salivary 
Cortisol + cortisone. 
Ratios of Cortisol over cortisone 
Plasma total Cortisol and cortisone 
For each subject the ratios of Cortisol over cortisone were calculated and values expressed 
as mean levels per study group (Table 4). Cortisol is the principal corticosteroid hormone 
and cortisone is considered a biologically inactive metabolite. Degradation finds place 
mainly in the liver and in normal conditions the ratio of plasma total Cortisol over cortisone 
(TF/TE) is about 7.5. In pregnancy the placenta is an additional source of cortisone, but it 
appeared that TF/TE was slightly lower than normal, although not significantly different. 
In the postpartum period TF/TE was slightly increased, but not different from mean normal 
or pregnant values. 
During OC usage plasma total Cortisol increases to about 3 times normal values, which is 
not the case with cortisone. As a result the ratio TF/TE is greatly increased in both OC-
groups, the M-group being even significantly higher than the S-group. This may indicate a 
relatively lower metabolism of Cortisol in the liver. 
Plasma free Cortisol and cortisone 
The ratio of the plasma free concentrations (FF/FE), shown in Table 4, is in all study groups 
4-5 times lower than TF/TE. This ratio of TF/TE is 1.60 in normal conditions, not signifi-
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cantly different from pregnant and postpartum. In both OC-groups the ratio of FF/FE is 
significantly increased, again indicating relatively less conversion of Cortisol into cortisone 
in the liver. In the M-group this ratio is significantly higher than in the S-groups, compara-
ble to the ratios of TF/TE. 
Salivary Cortisol and cortisone 
In saliva the ratio of Cortisol over cortisone (SF/SE) in normal conditions is 0,37, being no 
different from pregnant values. In both OC-groups and in the postpartum group this ratio is 
significantly increased. 
From these results it should be concluded that pregnancy has no influence on the propor-
tion of F : E, whereas usage of OC's is a factor that inhibits conversion of F into E in the 
liver as well as in the salivary gland. 
DISCUSSION 
By using the methods described in this study several defects of earlier investigations could 
be avoided. Equilibrium dialysis of undiluted plasma samples combined with specific RIA 
of Cortisol and cortisone in the dialysate provided reliable values for their plasma free con-
centrations. It appeared that in the pregnant and both OC groups mean plasma free Cortisol 
was significantly higher than normal. The slight but not significant increase in the postpar-
tum group was caused by a few women showing values above normal, indicating that at 
this time after pregnancy adrenal status was sometimes not yet normal. With regard to plas-
ma free cortisone, only the pregnant group showed significantly elevated levels. 
The best measure to demonstrate a state of hypercorticism is believed to be the level of 
plasma free Cortisol. From the results of the present study it should be concluded that at the 
end of pregnancy and during OC usage women are in a state of hypercorticism. However, 
considering results published earlier with regard to the daily rhythm of Cortisol in saliva, 
increased or decreased values of plasma free Cortisol at one time point during the morning 
may be caused by a shift in the daily rhythm [80,81]. This may also apply to the women in 
the study described here, which means that the hypercortisolism found may be a false effect 
caused by said peakshift. 
The determination of the plasma free fraction of steroid hormones, especially those that for 
the greater part are bound to high affinity binding proteins, is laborious, time consuming 
and prone to erroneous results. Already in the early sixties Shannon and coworkers [1-8] 
demonstrated a good correlation between salivary and plasma corticosteroids and they sug-
gested that the latter may be replaced by the former. In the subsequent period, where 
methods were improved, it was demonstrated that salivary corticosteroids, particularly Cort-
isol, was highly correlated with plasma free levels and was an even better measure for adre-
nocortical activity than plasma total Cortisol [82]. In the present study, however, contradic-
ting results were found. Although comparison of values of plasma free Cortisol indicated a 
hypercorticism at the end of pregnancy and during OC-usage and despite good correlation 
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between plasma free and salivary Cortisol, this was not reflected in salivary levels. It appe-
ared that in this regard salivary Cortisol was a less discriminating parameter. 
The finding that the differences between subjects with normal or high CBG with regard to 
salivary Cortisol are less than with regard to plasma free Cortisol are a consequence of the 
enzymatic activity of llß-HSD in the salivary gland. About 30% of free Cortisol is conver-
ted into cortisone and this percentage differs between groups. llß-HSD is an oxido-reduc-
tase which catalyzes the oxidation of Cortisol to cortisone in the presence of NADP and the 
reduction of cortisone to Cortisol in the presence of NADPH. The two activities are contai-
ned within one glycoprotein. Immunochemical analysis has demonstrated the presence in 
several tissues. However, each tissue preferentially exhibits only one activity: reductase or 
oxidase [83,84]. The direction of the enzymatic activity is dependent on the conditions pre-
sent in the particular cells/tissues. The exception seems to be the placenta, where the l lß-
HSD activity gradually changes from predominantly reductase to predominantly oxidase 
activity. However, recently it was demonstrated that also the presence of an oligosacchari-
de component on the enzym dictates its activity in the direction of reductase or dehydroge-
nase. With regard to the salivary gland, it has been suggested that here only the dehy-
drogenase part of llß-HSD is active, with less than 1% reductase activity. 
There are several hormonal factors that may influence the activity of llß-HSD. Data about 
this subject, however, are sometimes contrasting. Cortisol, a major substrate in human, 
exerts substrate inhibition at high concentrations [85]. On the other hand, it activates the 
enzyme by inducing enzyme synthesis, e.g. in fibroblasts [86]. 
Cortisone in relatively high concentrations exerts product inhibition, e.g. placenta [87,88], 
but in fibroblasts it stimulates dehydrogenation (F into E) [86]. With regard to progeste-
rone, this was demonstrated to inhibit llß-HSD activity in placenta [87], although such 
effect was not found by other investigators [89]. 
Cortisone is generally believed to be a biologically inactive metabolite of Cortisol, although 
the finding that in fibroblast cells cortisone more than Cortisol can induce aromatase activi-
ty may contradict this assumption. In glucocorticoid (GC) target cells, however, Cortisol 
exerts biological activity. Besides, the affinity of GC receptors for cortisone is less than for 
Cortisol. Considering the fact that in these target cells llß-HSD is present, the biological 
effect of Cortisol is regulated by this enzymatic activity. As a consequence, adrenocortical 
status will not only be related to absolute levels of Cortisol in blood, but concurrently to 
llß-HSD activity. Possibly the ratio of cortisolxortisone may give a better indication of 
adrenocortical or glucocorticoid status. The importance of cortisone levels in assessing 
glucocorticoid status has also been expressed by Mammami & Siiteri (1991) [86]. 
Cortisol is synthesized in the adrenals. Only part of the total amount released into blood 
will be available to target cells. On the one hand part of it is metabolized in the liver, about 
10-15% to cortisone, and of the rest about 90% is bound to CBG and albumine. Supposed 
that llß-HSD activity is a co-determinant of adrenocortical status any effect hereon caused 
by pregnancy or OC-usage may be deduced from the change in cortisolxortisone ratio 
determined for the free fraction of plasma and in saliva. 
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In normal conditions the ratio of plasma free Cortisol to plasma free cortisone appears to be 
about 1.60, which corresponds to values found in literature. In pregnancy this ratio is slight-
ly but not significantly lower. In both OC groups, in contrast, this ratio is significantly ele-
vated above normal. From these data it should be concluded that during OC-usage, but not 
at the end of pregnancy relatively more Cortisol can enter the target cells. 
If all plasma free cortisone is derived from plasma free Cortisol, the percentual conversion 
for the present study groups can be calculated: 
plasma free cortisone 
x 100 % 
plasma free Cortisol 
For the respective groups this percentage presented as mean ±SD (group) was: 39,53 ± 6,70 
% (N), 33.66 ± 9.48 % (pp), 45.47 ± 6.16 % (P), 21.24 ± 4.76 % (M), and 27.63 ± 7.57 % 
(S). It appeared that the highest percentage was found in the pregnant group, being signifi-
cantly different from the postpartum, Marvelon and Stediril group. A disturbing point in 
this comparison is, however, that in pregnancy cortisone is additionally derived from the 
placenta. The lowest percentage was found in the Marvelon group, being significantly dif-
ferent from all other groups. This could mean that in the Marvelon group the enzyme llß-
HSD is the least active. 
These calculated percentages are different from a percentage as calculated from total con-
centrations of Cortisol and cortisone. The percentage total cortisone with respect to total 
Cortisol was: 12.20 ± 2.25 % (N), 10.37 ± 2.77 % (pp), 13.45 ±2.66 % (P), 4.54 ± 1.17 % 
(M), and 5.93 ± 1.29 % (S), respectively. Again the lowest percentage was found in the 
Marvelon group, although not significantly different for the Stediril group. 
Provided that in the salivary gland only Cortisol can be converted into cortisone and not the 
reverse, and plasma free cortisone diffuses unchanged into saliva, the total concentration of 
salivary cortisone is the sum of plasma free cortisone plus the part of plasma free Cortisol 
that was metabolized. The conversion rate of plasma free Cortisol can be calculated by 
applying the following formula: 
salivary cortisone - plasma free cortisone 
x 100 % 
plasma free Cortisol 
For the present study groups this rate was 85.49 ± 38.08 % (N), 67.39 ± 35.34 % (pp), 63.09 
± 24.65 % (P), 88.53 ± 16.32 % (M) and 84.76 ± 25.98 % (S), respectively. No significant 
differences were found for these percentages between the study groups, probably due to the 
high variation. However, it is clear that the enzyme is much more active in the salivary 
gland than in the liver, especially in the normal group and when OCs are used. Also the 
data suggest that at the end of pregnancy the activity is lower than normal, which might 
have been a consequence of product inhibition by cortisone, but this does not hold true for 
the postpartum group. 
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The mechanism of the passage of Cortisol and cortisone from plasma to saliva was another 
subject of the present investigation. Although it is generally believed that non-protein-bound 
corticosteroids freely diffuse through the salivary gland, our results contradict this assump-
tion, because with the exception of the post-partum group, the sum of Cortisol + cortisone 
in saliva was significantly higher than the sum of Cortisol + cortisone free in plasma. There 
are several possibilities to explain this phenomenon: 
1. in the salivary gland water is resorbed, resulting in a concentration of constituents and 
consequently elevation of corticosteroid levels; 
2. proteins, in this case CBG and/or albumin pass from plasma to saliva by diffusion, taking 
along bound corticosteroids; 
3. CBG and/or albumin pass by ultrafiltration, with the same effect as mentioned in 2; 
4. corticosteroids are extracted from the blood by CBG present in the extravascular space 
as a result of sequestration, which leads to elevated binding of corticosteroids and relea-
se in saliva; 
5. CBG receptors are present on the membrane of cells of the salivary gland, which bind 
and internalize CBG and corticosteroids bound to it; 
6. CBG is present in the salivary gland cells due to de novo synthesis; in this case internal 
CBG acts as a "sink" for corticosteroids and keeps the gradient in the direction of the 
cells comparable to extravascular CBG as mentioned in part 4; 
7. glucocorticoid receptors are present in the salivary cell cytosol, acting in the same way 
as internal CBG in part 6. 
8. there is an unknown GC-binding protein present in the cell membranes of the salivary 
gland. 
In many aspects, structurally as well as physiologically, the salivary gland is comparable to 
the kidney. Both are excretory organs where from the capillaries water and several blood 
constituents are collected in the ducts to form a primary secrete. During passage through 
the ducts the fluid is modified by reabsorption of e.g. sodium ions to form the secundary 
secrete. In the salivary ducts, in contrast to kidneys, no water molecules are reabsorbed 
from the ducts [90]. This means that the first possibility, concentration of fluid, is unlikely. 
Diffusion of molecules through the membranes is restricted to lipid soluble compounds. 
Corticosteroids but no proteins can enter the saliva by diffusion, excluding possibility 2. 
Between the acinar cells of the salivary gland ultrafiltration can take place, but only mole-
cules with a molecular weight of less than approximately 300 dalton will enter the excre-
tion fluid. CBG and albumin, however, are relatively large proteins, and it is unlikely that 
they pass the acinar cells by ultrafiltration. CBG and albumin have been determined in sali-
va in very low concentrations. At first these proteins were considered as blood contami-
nants. Chu & Ekins [65] found some relation with concentrations in blood, but until now 
only very few data are available about the presence of CBG and albumin in saliva in rela-
tion to blood levels to give any indication about their origin. 
At many sites CBG is present in the extravascular space. In 1984 Stephenson et al. [91] 
found that in the inner medulla-papilla of the rat kidney CBG is accumulated to 4 times 
higher molar concentrations than in plasma. On the basis of their results they proposed a 
countercurrent exchange model for renewable extravascular sequestration of free corticos-
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terone (the active corticosteroid in the rat). The function of this extravascular CBG was 
thought to be to capture corticosterone and to allow aldosterone to occupy the mineralocor-
ticoid receptor. The developmental pattern of corticosteroid binding in renal papilla showed 
similarity to that of plasma CBG and the origin of the sequestered extravascular CBG appe-
ared to be the plasma CBG. Any extravascularly bound corticosterone is released again into 
the recurrent vasculature. The salivary gland shows a similar countercurrent vasculature. 
Moreover, the salivary gland is also a target organ for aldosterone comparable to the kid-
ney. In the light of these similarities between the salivary gland and the kidney it would not 
be surprising if in the former there would also be found a sequestration of CBG. As a con-
sequence, Cortisol, in humans, could be accumulated and subsequently excreted into saliva 
in higher amount than that expected from simple diffusion. Unfortunately, sequestration of 
CBG in the salivary gland has until now not been investigated. 
De novo CBG synthesis in the salivary gland is another possibility that can lead to accumu-
lation of Cortisol in the cell and subsequent release into saliva. In some glucocortoid target 
cells CBG has been determined intracellularly [92,93]. For example, in uterus an increase 
in intracellular CBG levels could be induced by estrogens, comparable to liver synthesis. 
According to Siiteri [94], CBG synthesis and transport to the cell membrane provides spe-
cificity to the target cells. In salivary gland cells such CBG synthesis has hitherto not been 
demonstrated, which leaves this possibility as an explanation for our findings. 
Cortisol accumulation in target cells may also procceed by the action of glucocorticoid or 
mineralocorticoid receptors. A prerequisite to fit in our model is that these receptors are 
cytosolic or anchored in the membrane to be able to trap Cortisol from the plasma. The dis-
cussion about a cytosolic or nuclear site for intracellular receptors, however, is still going 
on. In a recent report about immunohistochemical determination of progesterone receptors 
in the salivary gland, [95] showed that at least these receptors are retained in the nucleus. 
It is possible that for GC-receptors the regulation in target cells is different than for proge-
sterone and estrogen receptors. In recent publication (Akner et al. 1991) [96] it was demon-
strated that in human gingival fibroblasts GC-receptors are co-localized with extranuclear 
microtubuli, enabling the transport of GC through the cytoplasm to the nucleus. 
The last possibility suggested above, an unknown GC-binding protein in target cell mem-
branes, is supported by the results of Alléra & Wildt (1992a,b)[97,98]. These investigators 
demonstrated the presence of such a specific binding protein in vesicles of rat liver plasma 
membrane. It was excluded that the protein was CBG or GC-receptor. The affinity for 
corticosterone (in rats the counterpart of Cortisol) was even higher than with CBG. It appe-
ared that this protein, which they called GCC = glucocorticoid carrier, was a specific, high 
affinity binder, operating at physiological concentration of corticosterone in blood. 
Furthermore, influx as well as efflux of corticosterone was exhibited, with almost the same 
kinetic quality although efflux occured at a slow time-course. The conclusion of these inves-
tigators was that there is no passive diffusion of corticosterone but steroid transfer is a 
thermodynamically spontaneous and effective process whereby the steroid is transferred 
from CBG in the blood to the receptor inside the cell. 
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Summarizing the above, to explain our findings that the concentrations of salivary corticos-
teroids (Cortisol + cortisone) are significantly higher than those in free in plasma, it is most 
probable that comparable to rat liver cells a membraneous protein called GCC, plays a role 
in the accumulation of corticosteroids in the salivary gland; the steroid is bound to this 
GCC, transferred through the cytoplasm via GC-receptors connected with microtubuli and 
released again via the countercurrent mechanism as comparable to that in the kidney or via 
GCC efflux. 
Furthermore, the ratio of cortisohcortisone in saliva as well as free in plasma in the OC 
groups is higher than that in the normal and pregnant groups. This indicates an influence of 
OCs on the enzyme activity of llß-HSD in the salivary gland as well as in the liver. 
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GENERAL DISCUSSION 
The objective of the present study was to investigate the applicability of the assay of ste-
roids in saliva, particularly corticosteroids and progesterone, to assess on the basis of sali-
vary values the hormonal status of individual subjects. The final purpose of this study was 
to demonstrate that saliva can be used as an alternative biological medium for collecting 
data concerning corticosteroid concentrations to be employed as a better measure for asses-
sing the hormonal status of an individual than those from plasma. This latter consideration 
is based on the "Free Hormone Hypothesis" of Robbins & Rail (1957) [1]. In short, they 
pose that of a total amount of a particular hormone in blood only the free, non-protein-
bound fraction is biologically active. Since the formulation of this hypothesis two hormo-
nes have attracted great interest, namely thyroxin, which was the model compound for the 
"Free Hormone Hypothesis", and Cortisol. The interest for Cortisol can be explained by the 
fact that a concentration divergent from normal values in blood leads to explicit clinical 
symptoms. The best-known example is Cushing's syndrome due to overproduction of Corti-
sol [2,3]. As a result of the development of improved methods for the determination of the 
free fraction of Cortisol in blood it was be clearly demonstrated that Cushing's syndrome is 
associated with elevated levels of plasma free Cortisol [4,5]. This phenomenon is referred 
to as hypercorticism or hypercortisolism. The opposite, namely that increased plasma free 
Cortisol levels are associated with Cushingoid symptoms, does not hold true. For example, 
it appeared that due to the usage of estrogens the total concentration of Cortisol sometimes 
increased about 2-3 times, but Cushingoid symptoms were not observed. It should be noted, 
however, that the determination of free Cortisol in plasma not always led to unambiguous 
results and conclusions [6-8]. The same phenomenon has been observed with pregnant 
women [9,10]. 
The discrepancies concerning concentrations of free Cortisol in plasma could for the greater 
part be reduced to methodological aspects. Accordingly, when it was found that salivary 
Cortisol was strongly related with plasma free Cortisol [11], attention was directed toward 
saliva as an alternative biological medium. The underlying consideration was that Cortisol 
in saliva could only be derived from the free fraction in blood because, in contrast to ste-
roids, proteins cannot pass through membranes [12]. The (a)polarity of Cortisol permits this 
compound to diffuse through the salivary gland. The mechanism of this passage has been 
extensively described [13]. It was expected that, when using saliva to measure Cortisol 
concentrations, in conditions of elevated plasma total Cortisol but without Cushingoid symp-
toms, levels of salivary Cortisol would not be increased above normal. Unfortunately, lite-
rature data again showed no unambiguous results concerning salivary Cortisol concentra-
tions [14,15]. 
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An important confounding factor is the presence of the enzyme llß-hydroxysteroid dehy-
drogenase (llßHSD) in the salivary gland. The activity of this enzyme that converts Corti-
sol into cortisone disturbs the relation between plasma free Cortisol and salivary Cortisol. 
The existence of 1 lß-HSD in e.g. the salivary gland has been known for a long time and its 
activity has been mentioned to explain the lower concentration of Cortisol in saliva than 
that free in plasma [16,17,18]. Unfortunately, the knowledge about the conversion of Corti-
sol into Cortison for the measurement of Cortisol has hardly led to the selection of mono-
specific analytic methods for Cortisol, that is methods without interference by cortisone or 
other substances [18]. Particularly in direct immunoassays or immunoassays including 
extraction the cross-reactivity of cortisone will strongly influence the results. In the case of 
specific methods the presence and concentration of cortisone has only been determined in 
singular cases [19,20]. Hence, nothing is known about any influence of llßHSD on the 
relation between plasma free and salivary Cortisol. Besides, the influence of hormonal sta-
tus on the activity of llßHSD with regard to salivary corticosteroids has not been subject 
of investigation. 
The hitherto unsolved question whether in women using estrogens (in the form of oral con-
traceptives, OCs) or in pregnant women a state of hypercortisolism exists at the level of 
plasma free Cortisol and the question whether any hypercortisolism could be confirmed by 
measuring Cortisol in saliva by very specific methods, has led to the investigation described 
herein. Initially much effort was put into optimizing analytical methods in order to obtain 
reliable results. An extensive description of the applied methods to specifically measure 
Cortisol with sufficient sensitivity in plasma (total and free) and in saliva is given in Chapter 
2 [21]. Because cortisone was an important factor for the posed questions, this steroid was 
included in the study and has been measured with the same methods. 
A further confounding factor may be the daily rhythm of Cortisol. It has already been men-
tioned that differences in sampling time may prevent comparison of results [18]. For this 
reason in the present studies all samples were collected at the same time in the morning, 
i.e. at 9.00 h. In view of the objectives of this investigation the groups of subjects were 
carefully defined and selected. The first part of the study was directed to the effect of OCs 
on the parameters plasma total Cortisol, plasma free Cortisol, salivary Cortisol, plasma total 
cortisone, plasma free cortisone, salivary cortisone, and CBG. Two groups of women were 
included in this study: normal women and women using oral contraceptives. The women in 
the OC group used only Marvelon® (30 ug ethinylestradiol + 150 ug desogestrel) for more 
than six months. 
According to the "Free Hormone Hypothesis" any form of hypercortisolism was expected 
to be indicated by elevated concentrations of plasma free Cortisol compared to normal valu-
es. The applicability of salivary Cortisol as substitute for plasma free Cortisol should appear, 
besides a good correlation between these two parameters, from a similar or even better dis-
crimination between both study groups. From the results of the first part of the investiga-
tion it appeared that usage of OCs (Marvelon) led to the expected significant increase in 
CBG (from 892 ± 123 nmoVl, n=15, to 1534 ± 284 nmol/1, n=23), and plasma total Cortisol 
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(from 394 ± 107 nmol/1 to 1284 ± 315 nmol/1). Further, it appeared that plasma free Corti-
sol had increased after usage of OCs from 18.1 ± 7.95 nmol/1 to 32.3 ±9.03 nmol/1. A simi-
lar increase was observed for salivary Cortisol (from 9.2 ± 3.88 nmol/1 to 18.8 ± 6.92 
nmol/1), the ratio of free cortisol/salivary Cortisol being not significantly different (0.52 and 
0.58, resp.). Regarding the finding that the correlation between plasma free and salivary 
Cortisol was highly significant (p<0.001) it was concluded: a) that usage of Marvelon leads 
to a form of hypercorticolism at the level of plasma free Cortisol; and b) that salivary Corti-
sol gives the same information as plasma free Cortisol. However, obvious symptoms of 
hypercortisolism (Cushingoid symptoms) were not shown by the OC-women. 
Cortisone is regarded as a biologically inactive metabolite of Cortisol. Plasma total concen-
tration is about 12% (controles) to about 5% (OCs) of the total plasma Cortisol concentra-
tion. In plasma, cortisone is bound to CBG similarly as Cortisol but with lower affinity. It 
was found, that usage of OCs substantially had no effect on the total plasma concentration 
of cortisone. The increase in CBG resulted in a decrease of plasma free cortisone. This fin-
ding is in contrast to the observed increase in salivary cortisone. This discrepancy between 
plasma free and salivary cortisone can be explained by the activity of llßHSD in the sali-
vary gland, by which part of plasma (free) Cortisol is converted into cortisone and contri-
butes to the overall concentration of cortisone in saliva. This also explains the much lower 
correlation between plasma free and salivary cortisone. The ratio salivary/plasma free cort-
isone after OC usage is about two times higher than normal, in contrast to the ratio for Cort-
isol. It can be hypothesized that this is due to the fact that after use of OCs there is more 
free Cortisol available in plasma for passage and conversion. 
From these results it is evident that llß-HSD converts a considerable part of Cortisol into 
cortisone during transport through the salivary gland, but apparently this has no influence 
on the potential applicability of salivary Cortisol as a substitute for plasma free Cortisol. 
The apparent hypercortisolism at the level of plasma free and salivary Cortisol after OC 
usage, however, is not consistent with the absence of any observed Cushingoid symptoms. 
Absence of Cushingoid symptoms in the presence of continuously elevated concentrations 
of the biologically active (plasma free and optionally salivary) Cortisol may be explained 
by a kind of "resetting" of the feed-back system of the HPAA together with a decreased 
sensitivity of target organs. The occurence of a resetting of the HPAA has been suggested 
previously [22]. Decreased sensitivity of target organs may occur when the availability of 
the glucocorticoid receptor (GCR) has diminished by depletion or by competition of other 
compounds. Depletion of cytoplasmic receptor can occur in situations of long term eleva-
tion of effector compounds [23,24]. The major competitor for the GCR is progesterone, 
which exhibits a similar affinity as Cortisol and has been reported to compete with Cortisol 
for receptor binding sites on target cells [25]. However, OC-usage leads to a considerable 
decrease of progesterone concentrations. Another possibility for competition is by the 
components of the OC composition. It has been demonstrated that the major metabolite of 
the progestagenic component of Marvelon, 3-keto-desogestrel, binds to the progesterone 
receptor [26,27] and to the glucocorticoid receptor with high affinity [28]. 
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Another condition which has been subject of extensive studies related to saliva measure-
ments is human pregnancy. Pregnancy is accompanied with increased levels of CBG, plas-
ma total en plasma free Cortisol, indicating a state of hypercortisolism. An important diffe-
rence with OC-usage is that during pregnancy plasma progesterone as well as plasma corti-
sone increase considerably. With regard to the above discussion it seemed relevant to dete-
mine the effect of pregnancy on plasma free and salivary levels of Cortisol and optionally 
on the activity of 1 lßHSD. 
For this investigation samples (plasma and saliva) were collected from a group of 37 preg-
nant women four times during pregnancy. For non-pregnant control samples from the same 
group of women plasma and saliva were collected again at 6 weeks post partum. It is gene-
rally considered that at this time the hormonal status has returned to normal. The subjects 
were divided into 2 groups. In the one group sampling time was restricted to about 9.00 h 
to compare the results with those of the study concerning the effect of OCs. 
According to literature data progesterone shows no daily rhythm in normal conditions (no 
OCs, not pregnant). With regard to progesterone during pregnancy there are indications 
that at the end of the third trimester a daily rhythm has evolved [29]. This daily rhythm 
appears the inverse of that of Cortisol, i.e. in the evening higher values than in the morning. 
To demonstrate the existence of any daily rhythm of progesterone during pregnancy the 
second group of pregnant women was sampled at 16.00 h. 
The results of this study have been publisched (Chapter 3) [30]. The most remarkable fin-
ding was the excellent correlation between plasma free and salivary progesterone, which 
has been demonstrated only once before [31]. Both for the group as a whole as for indivi-
dual subjects this correlation was highly significant (p<0.0001 and p<0.005, resp.). 
The concentration of progesterone in saliva was about 50% of the plasma free concentra-
tion. This finding seems similar to the difference between plasma free and salivary Cortisol, 
where llßHSD is responsible for the decrease in salivary concentrations. Recently it was 
also demonstrated that in the salivary gland of healthy individuals progesterone is metabo-
lized to various metabolites [32]. Another cause of the "disappearance" of progesterone 
could be adsorption in the sampling device. It is kwown that progesterone strongly adsorbs 
onto several matrices. For this study saliva was collected in plastic cups. The samples were 
frozen and centrifuged before use. It was demonstrated that this method yields lower valu-
es than when samples are collected in glass tubes and sonificated before use. [Chapter 4, 
33]. Adsorption to the wall of the plastic cup as well as onto particulate matter may cause 
the loss of progesterone in the saliva samples. Together with some metabolism in the sali-
vary gland this may account for salivary levels being about half those free in plasma. 
Apparently the method of processing the salivary samples has no influence on the corre-
lation between plasma free and salivary progesterone. 
With regard to the question whether salivary progesterone corresponds with plasma free 
progesterone, the highly significant correlation between these two parameters is a positive 
indication herefore. Moreover, the increase in plasma free progesterone during pregnancy 
and the decrease postpartum is reflected in saliva. The question whether salivary progestero-
ne can substitute plasma free determinations can not be answered straightforward and 
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depends on the objective of the measurements. Saliva seems excellently suitable for moni-
toring studies. On the other hand, comparing morning and afternoon values the discrimina-
ting capacity of salivary progesterone apparently is less than that of plasma free progester-
one. The significant differences between plasma free progesterone in the morning and in 
the afternoon are less obvious in saliva. 
Apparently a daily rhythm of progesterone with significantly higher levels in the morning 
could be demonstrated only at the level of free plasma concentrations, whereas in saliva the 
same trend was visible but differences were not statistically significant. It should be noted 
that at the end of pregnancy plasma total progesterone also exhibited a daily rhythm, but in 
reverse direction, i.e. higher values in the afternoon and evening than in the morning. This 
finding corresponds with values found in the literature [29,34]. The discrepancy between 
the daily rhythm in plasma total and plasma free progesterone can be explained by the com-
petition between progesterone and Cortisol for binding places on CBG. In the morning the 
concentration of Cortisol increases above the capacity of CBG, displacing any progesterone 
and resulting in an increase of plasma free progesterone. This latter fraction will then be 
metabolized at a higher rate, resulting in a lowering of the total concentration. In the after-
noon the reverse will take place. 
In the same study group Cortisol and cortisone were measured. The results are given in 
Chapter 5 [35]. With regard to plasma total Cortisol and cortisone the expected increase in 
concentrations during pregnancy was observed in both morning and afternoon samples, 
with a significant decrease at 6 weeks postpartum. Plasma free Cortisol levels in the mor-
ning showed similar development as plasma total concentrations. Compared to postpartum 
values, especially those in the second half of pregnancy were significantly elevated. Since 
in that period plasma free cortisone is also increased, it should be concluded that then a 
condition of hypercorticism exists. 
Afternoon values of plasma free Cortisol tend to increase in the course of pregnancy, but no 
statistically significant differences were found between the sampling times. That means 
that if Cortisol should be measured only in the afternoon a condition of hypercortisolism 
would not have been detected. In contrast, plasma free cortisone concentrations are raised 
significantly in the morning as well as in the afternoon in the second half of pregnancy. 
Measuring Cortisol and cortisone in saliva both morning and afternoon values indicate a 
state of hypercorticism. As a consequence of the discrepancy between morning and after-
noon values the question whether pregnancy is associated with a state of hypercortisolism 
can not be answered unambiguously. Considering Cortisol as the major corticosteroid hor-
mone being biologically active, the following questions remain to be answered: 
1) Which time is relevant for sampling? 
2) Which parameter is a measure for hypercorticolism, plasma free Cortisol or salivary 
Cortisol? 
3) Which of these two parameters is a measure for biological availibility of Cortisol? 
For an answer to these questions reference is made to the study concerning the daily rhythm 
of corticosteroids as described in Chapter 6 [36]. In this study again three groups of women 
were included. Plasma was sampled during daytime (7.00 -16.00 h) and saliva was collec-
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ted from early morning until late evening (6.00 - 24.00 h). It appeared that when taking 
mean values the peak in the daily rhythm for salivary Cortisol and cortisone in the control 
group was 7.10 h en 7.26 h, respectively. During OC usage and at the end of pregnancy this 
peak was shifted to about 1-2 hours later in the morning. The course of the levels for sali-
vary Cortisol and cortisone were highly comparable. Unfortunately, the sampling of plasma 
started at 7.00 h and consequently the peak was missed and only the decrease of the peak 
in the daily rhythm could be observed. Plasma total cortisone showed only slight changes 
in concentrations. Plasma free Cortisol and salivary Cortisol behaved parallel. In contrast, 
the daily rhythm of salivary cortisone runs parallel to that of Cortisol, whereas plasma free 
cortisone hardly shows any rhythm. 
From the above it is evident that single-point measurements between 7 h and 10 h in the 
morning as have generally been employed in studies concerning the applicability of saliva-
ry Cortisol [37,38], greatly influence the results. It is recommended to collect samples in 
the afternoon, especially when normal subjects are to be compared with those using OC's 
or pregnant. 
Remains the question whether to use salivary Cortisol or plasma free Cortisol as a measure 
for hypercortisolism. Unfortunately, in the afternoon there exists a discrepancy between 
plasma free and salivary Cortisol. Whereas for plasma free Cortisol there is no difference 
between the three study groups, salivary Cortisol is increased in the OC group and the preg-
nant group of women. Which of these 2 parameters is superior for indicating a state of 
hypercortisolism (see question 2 above) remains difficult to answer. Considering plasma 
free levels as the biologically active fractions, the conclusion has to be that during OC-usa-
ge and at the end of pregnancy there exists no state of hypercortisolism. 
The measurement of salivary corticosteroids was intended to allow for replacement of the 
laborious measurement of plasma free levels. Given the results mentioned above, saliva 
does not entirely reflect plasma free levels. A confounding factor is the observation that 
absolute values of salivary Cortisol are not similar to plasma free levels. Part of the plasma 
free fraction is converted into cortisone by 1 lßHSD in the salivary gland and regarding the 
differences between the study groups the enzymatic activity may vary depending on hor-
monal status. 
Besides the search for a reliable parameter for hypercortisolism, it was also to be assessed 
which fraction - plasma free or salivary Cortisol - is a measure for biological activity. The 
presence and activity of the enzyme llß-HSD has been determined in corticosteroid target 
cells, e.g. in the salivary gland [39,40]. Due to the action of llßHSD the concentration of 
salivary Cortisol is about half that free in plasma, the other part being converted into corti-
sone. Moreover, as mentioned above the extent of enzymatic activity may vary depending 
on hormonal status. To circumvent the influence of llßHSD, cortisone may be included in 
the calculations. According to the "Free Hormone Hypothesis" and assuming a free diffu-
sion of corticosteroids from plasma to saliva, levels of salivary Cortisol + cortisone should 
be similar to that free in plasma regardless of the presence of 1 lßHSD. 
To examine this issue from five groups of women (normal women, women at the end of 
pregancy and 6 weeks postpartum, women using Marvelon or Stediryl as an oral contracep-
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tive) plasma and saliva were collected at 9.00 h a.m. and the concentrations of plasma free 
cortisone were compared with the corresponding salivary Cortisol + cortisone. The results 
of the measurements and calculations are given in Chapter 7. It appeared that, with the 
exception of the postpartum group all women had significantly higher values for salivary 
Cortisol + cortisone than for plasma free Cortisol + cortisone. These results indicate that eit-
her the "Free Hormone Hypothesis" does not apply to corticosteroids or that passage of 
these steroids does not proceed through free diffusion. This implicates that the mechanism 
of transport of corticosteroids from blood to saliva has to be revisioned. 
Scrutinizing the most recent literature not one but several modes of transport were found 
possible. These are summarized in the figure shown and will be explained below. 
In the figure the different levels of transport are divided into entry, movement and proces-
sing in the cell, and excretion. 
Part 1: Cortisol in plasma 
In plasma Cortisol exists in three different states: (la) presents plasma free Cortisol, up to 
about 4 %; (lb) presents albumine-bound Cortisol, up to about 6 %; and (lc) presents CBG-
bound Cortisol, up to about 90 %. Cortisone is not given in the figure for reasons of clarity, 
but herefor the same distribution applies with percentage of 16, 6 and 39%, respectively 
[41]. 
Part 2: Entry into the cell: 
Cortisol is a relatively small apolar compound and for a long time simple diffusion, (2a), 
through the membrane was considered the only way of entry into cells [42]. The same 
applies to cortisone. Any diffusion proces, however, implies transfer along a concentration 
gradient and, consequently, concentrations of Cortisol + cortisone in saliva can never be 
higher than those free in plasma. It is improbable that this mechanism is the only driving 
force in transport. 
Since many years a discussion has been going on between several working groups whether 
and to what extent albumine-bound and/or CBG-bound Cortisol may form an additional 
source of Cortisol supply [43-51]. Still, a subsequent delivery of Cortisol from these two 
proteins in plasma could not drive the transfer of Cortisol against a concentration gradient. 
The second mechanism (2b) is through pinocytosis, the ingestion of fluid and solutes via 
small vesicles [52], allowing rapid accumulation of ingested solutes. Acceptor sites at the 
cell membrane are the clathrin-coated pits. 
Endocytosis is also a mechanism by which CBG-bound Cortisol may enter the cell (2c). 
Internalization of protein-bound steroids has been described [53,54], but is related to a spe-
cific receptor and is very low. This mechanism has been described for several steroid bin-
ding proteins such as sex hormone binding globuline (SHBG), corticosteroid binding glo-
bulin (CBG) and aldosterone binding globulin (ABG). The mechanism of uptake of Corti-
sol through a CBG-receptor is further explained in part (2e). Simple endocytosis of CBG-
bound Cortisol will probably not take place. 
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Whereas the first three mechanisms described above are in principle non-specific for Corti-
sol and CBG, transport of Cortisol may take place via binding to specific acceptor molecu-
les. The first candidate is the glucocorticoid receptor (GCR). This mechanism is presented 
as (2d). 
Mineralocorticoid target organs, including the salivary gland [55-57] contain glucocorti-
coid receptors (GCRs) type I and II. The precise localization of receptors in a cell is still 
subject of debate. Although generally it is believed that GCRs are present in the cytoplasm, 
aldosterone receptors (GCR type I) have been demonstrated to be present in the membrane 
of monocytes and mononuclear leukocytes [58,59]. The presence of GCR type II (for gluco-
corticoids) in the cell membrane has been demonstrated in the nerve system of amphibian 
species and is suggested for other cell systems [58]. Thus, specific binding of Cortisol to 
GCR localized in the membrane is possible, although not yet demonstrated for the salivary 
gland. The mechanism of the coated pits (see above), that are known to contain various 
receptors, e.g. for cholesterol [52], may also apply to steroid receptors in target cells. 
Another receptor-mediated entry is via the CBG-receptor (2e). In many human tissues spe-
cific binding of CBG to the cell membrane of target tissues has been demonstrated 
[53,54,60-64]. Similar to binding to the GCR, Cortisol could be bound to CBG-receptor at 
coated pits and thus be internalized into the cell. With regard to the concomitant uptake of 
steroids, e.g. Cortisol, there are several reports that bound steroids enhance the binding of 
CBG to its receptors [53,60,62,64], although corticosteroids seem to inhibit the binding of 
CBG to rat liver membrane CBG receptors [65]. 
In (2f) the last mechanism is presented, namely the binding to the glucocorticoid carrier 
(GCC). Allera et al. [66,67] described the specific uptake of corticosterone in rat liver mem-
brane vesicles via GCC. It appeared that GCC is a thermolabile specific binding protein 
with high affinity for corticosteroids and the ability to accumulate steroids in the cytoplasm. 
The affinity of GCC for Cortisol was determined to be higher than to CBG. The conclusion 
of these authors was that uptake of corticosteroids in the rat liver cell is not a question of 
passive diffusion. 
Part 3: Release into the cell/cytoplasm: 
As indicated with (3a/b), Cortisol derived from plasma free, albumine-bound or CBG-bound 
Cortisol can easily diffuse through the membrane and is then released as either a free moving 
compound in the cytoplasm (3a) or bound to cytoplasmic components. It has been demon-
strated on the basis of the determination of intracellular mRNA analysis that CBG is not 
only synthesized in the liver where it is released in blood as transport protein, but also in 
other tissues, especially mineralocorticoid target tissues [68-70]. A CBG-like molecule 
additional to the glucocorticoid receptor has also been demonstrated in the cytosol of inf-
lammatory tissues [71]. The high affinity of CBG ensures a rapid binding of entering Corti-
sol (3b). 
The major binding component in corticosteroid target cells is the GCR (3c). Experiments 
carried out by Akner et al. [72] with antibodies agains GCR and microtubulin in gingival 
fibroblasts showed that GCR is cytoplasmatic and associated with microtubuli. Cortisol 
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binds to the GCR and after intracellular formation of a complex with various proteins, inclu-
ding heat shock proteins resulting in a so-called transportosome, this complex is transpor-
ted via the cytoskelet transportsystem [73-75] to the nucleus. 
Cortisol and CBG-bound Cortisol taken up by pinocytosis may uneventfully be transferred 
through the cytoplasm (3d). As discussed above (2c), the internalization of CBG, with or 
without Cortisol, has been demonstrated, but occurs probably via specific CBG receptors. 
In the case of binding of Cortisol to membrane-bound GCR (3c) in a target cell, a conforma-
tional change might release the GCR-cortisol complex into the cell, where it is further com-
plexed into a transportosome in the same way as mentioned above. Another way of uptake 
and release is through endocytosis/internalization. 
Similarly, specific binding of CBG to a high affinity binding protein has been demonstrated 
(see 2e). The major function of the formation of a CBG-receptor complex is still a matter 
of debate. On the one hand, complex formation leads to the generation of second messen-
ger (cAMP). On the other hand it can be internalized (3e) and is regarded as a transport 
mechanism to guide CBG to the nucleus [53,54,60,65,68]. However, the rate of interna-
lization is very small (about 3 %). The function of Cortisol in this mechanism seems to be 
the enhancement of the binding. It is unclear whether CBG or CBG-cortisol is released 
upon internalization. 
In (3f) is depicted the release of Cortisol from GCC. According to Alléra & Wildt [66,67], 
binding of Cortisol to GCC induces a thermodynamically driven transfer of corticosterone 
in the case of rat hepatocytes from CBG in the blood to the receptor inside the cell. Entry 
proceeds by conformational changes, leading to a lowering of affinity and delivering to 
cytoplasmatic GCR. Presumably, the same mechanism occurs with Cortisol in humans. 
Part 4: Fate of Cortisol inside the cell 
Once Cortisol is in the cytoplasm there are three destinations. When it is taken up in the 
microsomes (4a), either from the free state or internalized via vesicles, Cortisol is metaboli-
zed by llßHSD and converted into cortisone. In the salivary gland this enzymatic activity 
occurs to such an extent that about half of the concentration of Cortisol is converted into 
cortisone. 
Unmetabolized Cortisol may move to the opposite site of the cell (4b). 
Receptor-bound Cortisol, as is the case in most glucocorticoid target cells, is transported to 
the nucleus, where Cortisol exerts its biological activity (4c) by binding to the corresponding 
réponse element. This mechanism has been described extensively before [76,77]. The recep-
tor is recycled to the cytoplasm where it is degraded or used again for uptake of Cortisol. 
Cortisol itself is released into the cytoplasm and metabolized or ex/secreted. 
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Part 5: Excretion of Cortisol 
If diffusion is a process of uptake of Cortisol, excretion will take place via the same process 
for the same reasons (5a). Again, such a diffusion process will proceed along a concentra-
tion gradient. The same holds true for any cortisone, whether taken up in the same way as 
Cortisol by diffusion or after conversion. 
Active transport at the luminal site of the salivary cell from cytoplasma to saliva may occur 
against a concentration gradient if the mechanism involving the P-glycoprotein applies [78-
80]. It has been demonstrated that in the membrane of secretion/excretion organs at the 
luminal side of the cells a particular glycoprotein, P-glycoprotein, is present which appa-
rently binds and actively transports Cortisol, cortisone and aldosterone from within the cell 
to the corresponding lumen. In contrast, progesterone is bound to the P-glycoprotein, but is 
not transported. The active transport mentioned above is energy dependent and can proceed 
against a concentration gradient resulting in accumulation in the lumen. Although P-glyco-
protein has not yet specifically been demonstrated in the salivary gland, its presence in 
various transport epithelia makes it very plausible that it will be present here too. 
Cortisol, whether or not bound to CBG, that is taken up by pinocytosis can be excreted in 
the same way (5c, 5d). Pinocytosis is a mechanism consisting of both endocytosis and 
exocytosis. Cortisol, cortisone and CBG-bound Cortisol can be released at the luminal site 
of the salivary cell [52]. 
As is evident from the above, transport of Cortisol from plasma to saliva may proceed via 
many steps. Diffusion is generally accepted as the process by which corticosteroids pass 
from plasma to saliva, but if this were the sole mechanism it could never explain why con-
centrations of Cortisol + cortisone in saliva are significantly higher than those free in plas-
ma. Whether pinocytosis occurs in the salivary cell is unknown. If this process takes place, 
it is more probable that it is associated with membrane-bound receptor for Cortisol and/or 
CBG localized in clathrine-coated pits. 
The most acceptable explanation for transport of corticosteroids is the existence of the car-
rier, GCC. As mentioned above, the affinity of Cortisol for the GCC is higher than for CBG 
and as a result Cortisol will be captured by the GCC from CBG. Further, the uptake is selec-
tive and active, so that Cortisol can be accumulated in the cytoplasm. The presence of GCC 
in human cells, however, has to be demonstrated. 
To explain the finding of increased salivary levels of corticosteroids in comparison with 
plasma free levels, excretion at the luminal site of the salivary cell must also proceed against 
a concentration gradient. Diffusion and exocytosis alone will probably not meet this condi-
tion. Here the P-glycoprotein presents a candidate mechanism of excretion. Both Cortisol 
and cortisone are actively transported from the inside to the outside of the cell. Furthermore, 
the finding that during pregnancy only in the first months salivary Cortisol + cortisone are 
increased above plasma free Cortisol + cortisone can be explained by progesterone inhibi-
ting the transport of Cortisol. The results in OC-using women, where the difference between 
salivary Cortisol + cortisone is the highest compared with normal and pregnant women, 
support this hypothesis because during use of OCs progesterone is suppressed. 
136 
General discussion 
The explanation given above implies that CBG-bound Cortisol may additionally deliver 
Cortisol to target organs and that the free fraction not exclusively determines the biological 
activity of Cortisol. Remains the question how it can be explained that in conditions of rai-
sed plasma total Cortisol and CBG, such as in pregnancy or during OC usage, there are no 
clinical symptoms of hypercortisolism. Maybe in these situations the activity of llßHSD 
plays an important role in inactivating Cortisol inside the cells. Further explanations are a 
resetting of the setpoint of the feedback system of the HPAA, a decrease in the sensitivity 
of the adrenal for ACTH, and a refractoriness of target tissues [81]. 
As mentioned above one of the objects of this study was to get an indication about a possi-
ble influence of the activity of llßHSD on salivary corticosteroids in various conditions. 
Unfortunately, the presence of P-glycoprotein hampers any conclusion as to the activity of 
llß-HSD and even if this transportprotein really functions nothing is known about any 
difference in efficiency of transport of Cortisol and cortisone. The transport of metabolites 
of steroid hormones by P-glycoprotein is at the moment under investigation [78]. 
Assuming that Cortisol and cortisone show a comparable affinity for P-glycoprotein and are 
transported with similar efficiency, the differences in the ratios of the concentrations in 
saliva and free in plasma may provide an indication for the activity of 1 lßHSD. There appe-
ared to be no significant difference in the ratio of free cortisol/salivary Cortisol, free corti-
sone/salivary cortisone, free cortisol/free cortisone, salivary cortisol/salivary cortisone and 
total plasma cortisol/total plasma cortisone between normal and pregnant women. This 
means, that llßHSD activity is similar in these conditions without substrate or product 
inhibition or inhibition by progesterone. Both OC groups, however, differ from the normal 
and pregnant groups in some respects. Compared to normal women the OC women have 
relatively more cortisone in saliva in relation to plasma free cortisone (ratio salivary cortiso-
ne/free cortisone). Considering that salivary cortisone is for the greater part derived from 
plasma free Cortisol, and that plasma free Cortisol is increased above normal after OC usa-
ge, this finding may indicate that the activity of 1 lßHSD is increased during OC usage, 
which is conform data about enzym activation in the liver by OCs [82-86]. At least this 
conclusion applies for Cortisol - cortisone dynamics in the morning. It is possible that after 
the morning peak of Cortisol the situation is different. Solution of this problem awaits fur-
ther study. 
Summarized it can be concluded: 
(1) That passage of corticosteroids from plasma through the salivary gland into saliva part-
ly is an active energy-dependent process, involving transport of Cortisol and cortisone 
against a concentration gradient resulting in salivary levels being higher than those free 
in plasma. 
(2) That despite extensive metabolism salivary Cortisol is significantly correlated with plas-
ma free Cortisol. Thus, monitoring of Cortisol can be performed on the basis of salivary 
determinations. 
(3) That for the assessment of hypercortisolism, however, salivary Cortisol is less suitable. 
Salivary concentrations do not exactly reflect plasma free concentrations and the discri-
minating potency appears less than for plasma free Cortisol as demonstrated in the 
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groups studied. Considering plasma free Cortisol as a defined parameter of hypercortis-
olism saliva is not an alternative biological medium. 
(4) That the data concerning the daily rhythm of plasma free Cortisol indicate that at the 
end of pregnancy a form of hypercortisolism exists. In contrast, usage of OC does not 
lead to higher levels of plasma free Cortisol. Most remarkable finding was a shift in 
peak time for Cortisol in both pregnant and OC using women. Single-time point meas-
urement thus may readily lead to erroneous conclusions as a consequence of this shift 
in the peak to later in the morning. 
(5) That with regard to the daily rhythm of Cortisol saliva again does not always reflect 
plasma free Cortisol. In contrast to normal levels of plasma free Cortisol in OC using 
women over the day, Cortisol levels in saliva were increased. (6) That when plasma free 
Cortisol defines its biological activity, salivary Cortisol can not be used as an alternati-
ve. On the other hand, when the activity of 1 lß-HSD is a measure of the biological acti-
vity of Cortisol, salivary Cortisol + cortisone may present a better parameter than plas-
ma free Cortisol alone. Unfortunately, conclusions of the activity of 1 lß-HSD can not 
be given. 
The results of this study strongly indicate that passage of Cortisol from plasma to saliva is 
not merely passive diffusion, but rather at least partly a specific energy dependent process. 
Both uptake at the vascular site and release at the luminal site probably proceed through 
specific binding proteins against a concentration gradient. This phenomenon could explain 
the finding that concentrations of the corticosteroids Cortisol + cortisone are higher in sali-
va than could be expected on the basis of plasma free levels. Furthermore, not only free 
Cortisol is taken up and transported. The existence of a GCC protein at the vascular site of a 
salivary gland cell with an affinity for Cortisol higher than that of CBG consequently leads 
to the conclusion that also CBG-bound Cortisol may enter the cell. 
Further Research 
The first objective of this study was to determine whether saliva can be used as an alterna-
tive biological medium to assess the hormonal status of humans with regard to corticos-
teroids. The answer has to be no. It remains a matter of debate which parameter, plasma 
free or salivary Cortisol, is a measure for hypercortisolism. Data after OC usage or in preg-
nancy compared with those of normal women are conflicting. The experiments should be 
extended with samples collected all over the day for 24 hours. Then plasma free and sali-
vary Cortisol and cortisone should be measured. The area under the curve may be a better 
measure to determine a state of hypercortisolism in certain conditions in relation to normal 
values. 
The second objective was to deduce the activity of llßHSD as well as any change in enzy-
matic activity in several conditions on the basis of values of Cortisol and cortisone in plas-
ma and saliva. Initially, the basic assumption was that corticosteroids pass from plasma to 
saliva by simple diffusion. The results presented, however, contradict this assumption and 
passage seems to involve an active process. Consequently, too many confounding factors 
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prevent conclusions about this subject. Maybe it would contribute to our understanding of 
the transport of corticosteroids through the salivary gland if an extensive study on the acti-
vity of llß-HSD in the salivary gland could be performed with regard to several hormonal 
conditions. In addition, the half-life of llß-HSD may be relevant with regard to its activity 
over the day. 
Whether protein-bound plasma corticosteroids contribute to levels found in saliva also 
remains a matter of debate. For example, the ratio of CBG/free plasma cortisol/GCC and 
possibly the influence of hormonal status on this ratio may add to explain varying concen-
trations in saliva. More research is needed to solve this problem. Investigation should relate 
to 1) uptake in the cells, and 2) secretion/excretion at the luminal side of the salivary gland. 
With regard to item 1) the question is what uptake processes take place at the plasma side. 
These may involve one or more mechanisms involving diffusion, membrane-bound carrier 
proteins or membrane-bound receptors. Similarly, the presence of P-glycoprotein at the 
luminal site of the salivary gland should be assessed and its action with regard to corticos-
teroids determined. 
Another interesting feature is the influence of progesterone in the above mentioned mecha-
nisms. It is not known how progesterone passes from blood to saliva and what mechanisms 
are involved. Because the sampling methods used precluded correct values for progestero-
ne in saliva, in further studies these methods have to be optimized. This will permit conclu-
sions about what fraction of plasma free progesterone will ultimately be found in saliva. 
Relating concentrations of Cortisol, cortisone, progesterone and any major metabolite of 
progesterone may give further insight into any metabolism in the salivary gland and inter-
ference during uptake and/or secretion/excretion of the steroids. 
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SUMMARY 
Chapter 1: Introduction 
In Chapter 1 is explained in which form Cortisol appears in plasma, i.e. with high affinity 
bound to CBG (corticosteroid-binding globulin), with lower affinity to albumin and as an 
unbound, free hormone. Generally, the free form is considered the biologically active com-
ponent and an increase in the concentration of free Cortisol is associated with severe clini-
cally demonstrable abnormalities. A change in this concentration, however, can not be dedu-
ced from a total plasma concentration of Cortisol due to the binding proteins and the action 
of the negative feed-back system. Accordingly, much attention has been given to the rela-
tion between total and free plasma Cortisol on the one side, and to the measurement of free 
Cortisol in plasma on the other hand. The fact is, that the latter has led to contradictory 
results, which can be attributed to the analytical methods used. 
The demonstration that Cortisol can be measured in saliva as well and that salivary values 
form a good reflection of plasma free Cortisol, has stimulated a whole series of inves-
tigations. The final conclusion was, in short, that Cortisol in saliva is derived from the free 
fraction in plasma by simple diffusion and therefore represents a good parameter for its 
biological activity. 
The study described in this thesis was directed at the relation between free Cortisol in plas-
ma and salivary Cortisol in conditions where the total concentration of Cortisol in plasma is 
markedly increased with respect to normal, whereas this is not associated with symptoms, 
that indicate an increase in plasma free Cortisol. By way of introduction an extensive litera-
ture study was conducted regarding this subject, the results of which are summarized in 
Table 1 and 2. 
Additionally, literature data with regard to plasma free progesterone and salivary progester-
one as well as data referring to the presence and the activity of the enzyme llß-HSD (11-
beta-hydroxysteroid dehydrogenase) are given in Table 3,4 and 5 respectively. Progesterone 
was included in the study because this hormone may influence the binding of Cortisol to 
plasma proteins and consequently, due to displacement, the concentration of plasma free 
Cortisol. llß-HSD was included in the study because this enzyme is present in the salivary 
gland, here converts Cortisol into cortisone and consequently affects the concentrations of 
salivary Cortisol and cortisone. 
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Chapter 2: The effect of oral contraceptives on plasma free and 
salivary Cortisol. 
Chapter 2 describes the results of an investigation regarding the effects of oral contracepti-
ves (OCs) on the concentrations of plasma CBG, plasma total and free Cortisol, plasma total 
and free cortisone, and salivary Cortisol and cortisone. 
It is recognized that due to the estrogenic component in OCs the concentration of CBG in 
plasma increases. This results in a concomitant increase in plasma total Cortisol whereas in 
situations of OC usage no symptoms of pathologically increased Cortisol are observed. The 
expectation that in such cases free Cortisol will be in the normal range could not be demon-
strated in earlier studies. 
In the study described here the parameters mentioned above were measured with highly 
accurate methods to ascertain whether free Cortisol in plasma of OC using women was 
increased with respect to normal values (control group). Additionally, it was ascertained 
whether values found for free Cortisol in plasma were comparable to those in saliva. 
Moreover, with regard to the known activity of llß-HSD in the salivary gland cortisone 
was also measured in the same plasma and saliva samples. 
Chapter 3: Salivary progesterone excellently reflects free and 
total progesterone in plasma during pregnancy. 
In Chapter 3 the investigation regarding the relation between plasma total and free proge-
sterone and salivary progesterone during pregnancy is described. Progesterone is a hormo-
ne, the concentration of which increases considerably in the course of pregnancy. This ste-
roid hormone shows much similarity to Cortisol with regard to binding to plasma proteins 
and passage from plasma to saliva. This was the reason to investigate how far salivary valu-
es of progesterone correspond with free plasma values. 
For this study plasma and saliva samples were collected from pregnant women at 4 time 
points during pregnancy and as a control at 6 weeks postpartum. To be able to measure the 
above mentioned parameters analytical methods were adapted, improved and developed in 
order to obtain accurate results. 
Chapter 4: The effect of pretreatment of saliva on steroid hor-
mone concentrations. 
In Chapter 4 the results of an investigation concerning the effect of pretreatment of saliva 
samples on the final results of steroid analyses are given. A standard method for collecting 
and processing saliva prior to analysis is the collection of saliva in plastic cups, freezing 
and thawing the samples to make them less viscous, centrifugation of the samples in plastic 
tubes to remove solid particles. Supernatant fluid is then used for measurements and con-
sists of clear, easily pipettable liquid. An alternative method of processing is to collect sali-
va in plastic cups, freeze and thaw it, afther which the saliva samples are sonificated to 
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obtain a though not entirely clear, yet easily pipettable liquid. In this case the samples were 
stored in glass tubes. 
Reason for this investigation was the fact, that in the first method of processing sometimes 
inexplicable losses of steroid hormone, particularly progesterone, were found. To investiga-
te the effect of pretreatment several dozens of saliva samples were collected from men, 
women and children. Each sample was divided into 2 portions, one portion of which was 
treated with the centrifugation method and the other with the sonification method. With 
regard to the measured steroids the effect of both methods was compared for Cortisol, corti-
sone, progesterone, 17-hydroxy-progesterone, testosterone, androstenedione and oestradiol. 
Chapter 5: Differences between concentrations of salivary Corti-
sol and cortisone and of free Cortisol and cortisone in plasma 
during pregnancy and postpartum. 
In Chapter 5 the results of an investigation are described in which in the same study group 
and with the same methods as in Chapter 3 Cortisol and cortisone were measured in plasma 
(total and free) and in saliva, both in the morning and in the evening. This investigation 
was intended to demonstrate the relation between corticosteroids in saliva and free in plas-
ma during a period (pregnancy) in which in blood the concentrations of both CBG and total 
Cortisol increase considerably. The samples collected at 6 weeks postpartum served as con-
trols (normal values). Additionally, it was attempted to get insight in the activity of the 
enzyme llß-HSD in the salivary gland and a possible influence of pregnancy on this acti-
vity. This was investigated by means of the ratio Cortisol : cortisone in plasma (free frac-
tion) as well as in saliva. 
Chapter 6: The effect of oral contraceptive use and pregnancy 
on the daily rhythm of Cortisol and cortisone in saliva. 
Chapter 6 describes the investigation concerning the effect of use of oral contraceptives 
(OCs) and of pregnancy in comparison with the normal situation on the daily rhythm of the 
corticosteroids Cortisol and cortisone. OC usage and pregnancy lead to an increase in the 
concentration of Cortisol in plasma to a level comparable to that in Cushing's syndrome. 
However, in contrast to Cushing's syndrome where the daily rhythm of Cortisol usually no 
longer exists, this rhythm pertains in pregnancy and OC usage. 
It is known that the peak of Cortisol appears in early morning. In most previous studies for 
the measurement of plasma free and salivary Cortisol, samples were collected between 8 
and 10 h, a period of time with marked changes in concentrations of Cortisol. Contradicting 
results may therefore partly be explained by the influence of the daily rhythm. 
In this study an investigation was performed to compare the daily rhythm of Cortisol in OC 
using and pregnant women in comparison with a group of normal women. However, becau-
se frequent sampling of blood is stressing and because Cortisol in saliva is considered to 
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give a good reflection of plasma free Cortisol, the present investigation was conducted on 
the basis of the measurement of Cortisol in saliva. Three groups of women were involved in 
the study: 10 pregnant women; 11 women using low-estrogen OCs; and 12 normal women. 
Saliva samples were collected at intervals between 5.00 h until 24.00 h. It was known that 
the concentration of Cortisol in saliva amounts to about 50 % of that free in plasma as a 
consequence of the conversion into cortisone by the enzyme llß-HSD in the salivary gland. 
Thus cortisone in saliva is partly derived from plasma free cortisone, partly from plasma 
free Cortisol. For this reason cortisone was measured in all samples too. 
From a limited number of women it was possible to collect blood samples spread over the 
day. In these cases plasma total and free Cortisol and cortisone were also determined. 
Chapter 7: The relation between Cortisol and cortisone in saliva 
and in plasma in various hormonal conditions. 
In Chapter 7 the results are described of an investigation regarding the relation between 
plasma free Cortisol and cortisone and salivary Cortisol and cortisone and a possible influ-
ence of hormonal status on this relation. 
The results given in Chapter 5 indicated that the ratio of plasma free to saliva Cortisol and 
cortisone and of the ratio Cortisol to cortisone changed in the course of pregnancy. This 
indicated an influence of factors related to pregnancy on the passage of the corticosteroids 
from plasma to saliva and on the conversion of Cortisol into Cortison. To get further insight 
in the influence of hormonal factors the study was extended to women using low-estrogen 
oral contraceptives and to a control group. Cortisol and cortisone were measured in plasma 
(total and free) and saliva in five groups of women: 1) normal, non-pregnant non-OC-using 
women; 2) pregnant women at the end of the third trimester; 3) women at 6 weeks postpar-
tum; 4) women using Stediril; 5) women using Marvelon. 
Besides Cortisol and cortisone also CBG was measured in the plasma samples. Values and 
ratios for Cortisol and cortisone were compared for all the study groups. 
Chapter 8: General discussion. 
In Chapter 8 the results of the overall study were summarized in short. The principal con-
clusion was that in some situations the concentration of Cortisol + cortisone in saliva is hig-
her than would be expected on the basis of the concentration of Cortisol + cortisone free in 
plasma. This finding indicates, that not only the free fraction is transported by diffusion 
through the salivary gland, but probably also an active proces via specifically binding pro-
teins plays a role herein. 
The various possibilities of specifically binding proteins at both the plasma side and at the 
saliva side of salivary gland cells are discussed, as well as their functioning. 
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Hoofdstuk 1: Inleiding 
In Hoofdstuk 1 wordt uitgelegd in welke vormen Cortisol in plasma voorkomt, namelijk 
sterk gebonden aan CBG (corticosteroidbindend globuline), matig sterk gebonden aan albu-
mine en als ongebonden, vrij hormoon. Algemeen wordt de vrije vorm gezien als de biolo-
gisch actieve component en een verhoging of verlaging van de concentratie vrij Cortisol in 
plasma gaat gepaard met ernstige klinisch aantoonbare afwijkingen. Een verandering in 
deze concentratie is echter als gevolg van de bindende eiwitten en de werking van een nega-
tief feed-back systeem niet direct af te leiden uit een totale plasmaconcentratie van Cortisol. 
Derhalve is er veel aandacht besteed aan enerzijds de relatie totaal versus vrij plasmacorti-
sol, anderzijds aan de meting van de concentratie vrij Cortisol in plasma. Deze laatste heeft 
namelijk eerder geleid tot tegenstrijdige resultaten, die voor een deel te wijten waren aan 
de toegepaste analysemethoden. 
De aantoning, dat Cortisol ook gemeten kan worden in speeksel en dat de speekselwaarden 
een goede reflectie vormen van vrij plasmacortisol, heeft geleid tot een hele serie onder-
zoeken. De eindconclusie was, kort samengevat, dat Cortisol vanuit de vrije fractie in plas-
ma door simpele diffusie in speeksel terecht komt en daardoor een goede parameter is voor 
de biologische activiteit ervan. 
Het in deze thesis beschreven onderzoek was gericht op de relatie tussen vrij Cortisol in 
plasma en speekselcortisol in condities, dat de totale concentratie van Cortisol in plasma 
duidelijk verhoogd is ten opzichte van normaal, terwijl dit niet gepaard gaat met sympto-
men die duiden op een verhoging van vrij plasmacortisol. Als inleiding is een uitgebreide 
literatuurstudie verricht over dit onderwerp en de resultaten zijn samengevat in Tabel 1 en 
2. 
Ter aanvulling zijn literatuurgegevens betreffende vrij plasmaprogesteron en speekselpro-
gesteron, alsmede gegevens betreffende het voorkomen van en de activiteit van het enzym 
llß-HSD (11-beta-hydroxysteroid dehydrogenase) weergegeven in respectievelijk Tabel 3, 
4 en 5. Progesteron werd in de studie betrokken, omdat dit hormoon invloed kan hebben op 
de binding van Cortisol aan plasmaeiwitten en derhalve, ten gevolge van verdringing, op de 
concentratie van plasma vrij Cortisol. llß-HSD werd in de literatuurstudie betrokken, omdat 
dit enzym aanwezig is in de speekselklier, hier Cortisol omzet in Cortison en als gevolg 
invloed heeft op de concentratie van speekselcortisol. 
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Hoofdstuk 2: Het effect van orale contraceptiva op plasma vrij 
en speeksel Cortisol. 
In Hoofdstuk 2 worden de resultaten beschreven van een onderzoek naar de effecten van 
orale contraceptiva (OC's) op de concentraties van plasma-CBG, plasma totaal en vrij Cort-
isol, plasma totaal en vrij Cortison, en speekselcortisol en -Cortison. 
Het is bekend, dat als gevolg van de estrogene component in OC's de concentratie CBG in 
plasma stijgt. Dit resulteert in een gelijktijdige toename in totaal plasmacortisol, terwijl er 
in situaties van OC-gebruik geen symptomen van pathologisch verhoogd Cortisol worden 
waargenomen. De verwachting, dat in zo'n geval vrij Cortisol in een normaal bereik zal lig-
gen, kon in eerdere studies niet eenduidig worden aangetoond. 
In het hier beschreven onderzoek werden de bovengenoemde parameters gemeten met zeer 
nauwkeurige methoden om na te gaan of vrij Cortisol in plasma van OC-gebruikende vrou-
wen wel of niet verhoogd was ten opzichte van normale waarden (controlegroep). Daarnaast 
werd bekeken of in plasma gevonden waarden voor vrij Cortisol vergelijkbaar waren met 
die in speeksel. Bovendien werd, gezien de bekende activiteit van llß-HSD in de speeksel-
klier, ook Cortison gemeten in dezelfde plasma- en speekselmonsters. 
Hoofdstuk 3: Speeksel progesteron reflecteert uitstekend vrij en 
totaal progesteron in plasma tijdens de zwangerschap. 
In Hoofdstuk 3 is het onderzoek beschreven naar de relatie tussen plasma totaal en vrij pro-
gesteron en speekselprogesteron tijdens de zwangerschap. Progesteron is een hormoon, dat 
aanzienlijk in concentratie stijgt in de loop van de zwangerschap. Dit steroidhormoon ver-
toont veel gelijkenis met Cortisol wat betreft binding aan plasmaeiwitten en overgang van 
plasma naar speeksel. Dit was aanleiding om na te gaan in hoeverre speekselwaarden voor 
progesteron overeenkwamen met de vrije plasmawaarden. 
Voor het onderzoek werden plasma- en speekselmonsters verzameld van zwangere vrou-
wen op 4 tijdstippen tijdens de zwangerschap en ter controle 6 weken post partum. Om de 
bovengenoemde parameters te meten werden analysemethoden aangepast, verbeterd en ont-
wikkeld om tot nauwkeurige resultaten te komen. 
Hoofdstuk 4: Het effect voor vóórbehandeling van speeksel op 
steroidhormoonconcentraties. 
In Hoofdstuk 4 worden de resultaten gegeven van een onderzoek naar het effect van de 
voorbewerking van speekselmonsters op de uiteindelijke resultaten van steroidanalysen. 
Een standaardmethode voor het verzamelen en opwerken van speeksel vóór een analyse is 
het opvangen van speeksel in plastic potjes, het invriezen en ontdooien van de monsters om 
ze minder visceus te maken, en daarna het centrifugeren van de monsters in plastic buizen 
om vaste deeltjes te verwijderen. Bovenstaande vloeistof wordt dan voor de meting gebruikt 
en bestaat uit een heldere, makkelijk pipetteerbare vloeistof. Een alternatieve methode van 
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opwerken is het opvangen van speeksel in plastic potjes, invriezen en ontdooien, terwijl 
daarna de speekselmonsters worden gesonificeerd om een weliswaar niet geheel heldere, 
maar wel makkelijk pipetteerbare vloeistof te verkrijgen. Het bewaren van de monsters 
gebeurde in dit geval in glazen buizen. 
Aanleiding tot dit onderzoek was het feit, dat met de eerste opwerkingsmethode soms onver-
klaarbare verliezen van steroidhormoon, met name progesteron, optraden. Om het effect 
van de voorbewerking te onderzoeken werden vele tientallen speekselmonsters verzameld 
van mannen, vrouwen en kinderen van zeer uiteenlopende leeftijd. Elk monster werd ver-
deeld in 2 porties, waarvan de ene portie werd behandeld met de centrifugatiemethode en 
de andere met de sonificatiemethode. Wat betreft de gemeten Steroiden werd het effect van 
beide methoden vergeleken voor Cortisol, Cortison, progesteron, 17-hydroxy-progesteron, 
testosteron, androsteendion en oestradiol. 
Hoofdstuk 5: Verschillen tussen concentraties van speeksel Cort-
isol en Cortison en van vrij Cortisol en Cortison in plasma tijdens 
de zwangerschap en post partum. 
In Hoofdstuk 5 worden de resultaten beschreven van een onderzoek, waarbij in dezelfde 
onderzoeksgroep en met dezelfde werkwijzen als beschreven in Hoofdstuk 3 Cortisol en 
Cortison werden gemeten in plasma (totaal en vrij) en in speeksel, zowel 's morgens als 's 
middags. Met dit onderzoek werd beoogd de relatie aan te tonen tussen de corticosteroiden 
in speeksel en vrij in plasma tijdens een periode (zwangerschap), dat in het bloed de con-
centraties van zowel CBG als totaal Cortisol enorm toenemen. De monsters die 6 weken 
post partum verzameld werden, dienden ter controle (normaalwaarden). Daarnaast werd 
getracht inzicht te krijgen in de activiteit van het enzym llß-HSD in de speekselklier en 
een eventuele invloed van de zwangerschap op deze activiteit. Dit werd onderzocht aan de 
hand van de verhouding Cortisol : Cortison zowel in plasma (de vrije fractie) als in speek-
sel. 
Hoofdstuk 6: Het effect van het gebruik van orale contraceptiva 
en zwangerschap op het dagritme van Cortisol en Cortison. 
In Hoofdstuk 6 wordt het onderzoek beschreven naar het effect van het gebruik van orale 
contraceptiva (OC's) en van zwangerschap in vergelijking met een groep normale vrouwen 
op het dagritme van de cortisosteroiden Cortisol en Cortison. OC-gebruik en zwangerschap 
leiden tot een toename in de concentratie van Cortisol in plasma tot een niveau, dat vergelijk-
baar is met dat in Cushing syndroom. In tegenstelling tot Cushing syndroom, waarbij het 
dagritme van Cortisol niet langer bestaat, blijft echter dit ritme behouden tijdens zwanger-
schap en OC-gebruik. 
Het is bekend, dat de piek van Cortisol optreedt vroeg in de morgen. In de meeste eerdere 
onderzoeken voor de meting van plasma vrij en speekselcortisol werden monsters verza-
meld tussen 8.00 en 10.00 uur, een tijd van grote veranderingen in concentraties van corti-
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sol. Tegenstrijdige resultaten kunnen daarom gedeeltelijk verklaard worden door de invloed 
van het dagritme. 
In deze studie werd een onderzoek uitgevoerd om het dagritme van Cortisol te vergelijking 
in OC-gebruikende en zwangere vrouwen in vergelijking met een groep normale vrouwen. 
Omdat echter frequent afnemen van bloed vervelend is en omdat Cortisol in speeksel gezien 
wordt als een goede afspiegeling van plasma vrij Cortisol, werd dit onderzoek gedaam op 
basis van de meting van Cortisol in speeksel. Er werden drie groepen vrouwen betrokken in 
de studie: 10 zwangere vrouwen, 11 vrouwen die laaggedoseerde OC's gebruikten; en 12 
normale vrouwen. Speekselmonsters werden verzameld tussen 5.00 en 24.00 uur. Het was 
bekend, dat de concentratie Cortisol in speeksel ongeveer 50 % bedraagt van die vrij in plas-
ma als gevolg van de omzetting in Cortison door het enzym llß-HSD in de speekselklier. 
Cortison in speeksel is dus gedeeltelijk afkomstig van plasma vrij Cortison en gedeeltelijk 
van plasma vrij Cortisol. Daarom werd ook Cortison gemeten in alle monsters. 
Het was mogelijk om van een beperkt aantal vrouwen ook bloed over de dag te verzame-
len. In deze gevallen werd ook plasma totaal en vrij Cortisol en Cortison bepaald. 
Hoofdstuk 7: De relatie tussen Cortisol en Cortison in speeksel 
en in plasma in diverse hormonale condities. 
In Hoofdstuk 7 worden de resultaten beschreven van een onderzoek naar de relatie tussen 
Cortisol en Cortison vrij in plasma en in speeksel en de eventuele invloed van hormonale 
status op deze relatie. 
De resultaten, die gegeven worden in Hoofdstuk 5 duiden erop, dat de verhouding plasma 
vrij tot speeksel Cortisol en Cortison en de verhouding Cortisol tot Cortison veranderde in de 
loop van de zwangerschap. Dit duidde op een invloed van hormonale factoren, die gepaard 
gaan met zwangerschap, op de overgang van de corticosteroiden van plasma naar speeksel 
en op de omzetting van Cortisol in Cortison. Om meer inzicht te krijgen in de invloed van 
hormonale factoren werd het onderzoek uitgebreid met vrouwen, die laaggedoseerde orale 
contraceptiva gebruiken en met een controle groep. Cortisol en Cortison werden gemeten in 
plasma (totaal en vrij) en in speeksel bij vijf groepen vrouwen: 1) normale, niet-zwangere, 
niet-OC-gebruikende vrouwen; 2) zwangere vrouwen aan het einde van het derde trimes-
ter; 3) vrouwen 6 weken post partum; 4) vrouwen die Steriril gebruiken; 5) vrouwen die 
Marvelon gebruiken. 
Naast Cortisol werd ook CBG gemeten in de plasmamonsters. De waarden en ratio's voor 
Cortisol en Cortison werden voor alle groepen vergeleken. 
Hoofdstuk 8: Algemene discussie. 
In Hoofdstuk 8 worden in het kort de resultaten van het totale onderzoek samengevat. De 
voornaamste conclusie was, dat in sommige gevallen de concentratie Cortisol + Cortison in 
speeksel hoger was dan verwacht kon worden op basis van de concentratie Cortisol + Cort-
ison vrij in plasma. Deze bevinding duidt erop, dat niet alleen de vrije fractie door middel 
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van diffusie getransporteerd worden door de speekselklier, maar dat waarschijnlijk ook een 
actief proces via specifiek bindende eiwitten hierbij een rol speelt. 
De diverse mogelijkheden van specifiek bindende eiwitten aan zowel de plasmakant als 
aan de speekselkant van speekselkliercellen, alsmede de werking ervan worden uitvoerig 
besproken. 
156 
Samenvatting 
DANKWOORD 
Alle in deze thesis beschreven experimenten werden uitgevoerd op de afdeling 
Experimentele en Chemische Endocrinologie van het St. Radboud Ziekenhuis in Nijmegen. 
Het hoofd van deze afdeling, Prof.dr. ThJ. Benraad wil ik in ieder geval bedanken voor de 
mogelijkheden en faciliteiten. Verder wil ik iedereen bedanken die vrijwillig meegedaan 
heeft aan de experimenten, omdat anders dit onderzoek niet mogelijk zou zijn geweest. 
Tevens past hier een woord van dank aan de heer J.A. Hofman voor zijn deskundige bege-
leiding van de werkzaamheden en de uitvoerige wetenschappelijke discussies. 
CURRICULUM VITAE 
De schrijfster dezes werd geboren op 28 september 1952 in Heerlen. Na het doorlopen van 
de lagere meisjesschool in Nieuw-Lotbroek werd in 1971 op het St. Janscollege in Hoens-
broek het diploma gymnasium-ß behaald. Daarna volgde een studie biologie aan de 
Katholieke Universiteit van Nijmegen, welke afgesloten werd met het doctoraal in 1977. 
Na 1 jaar op de afdeling Moleculaire Biologie van de KUN in het kader van een TAP-rege-
ling kreeg zij de mogelijkheid door middel van herhaalde tijdelijke aanstellingen te werken 
op de afdeling Endocrinologie van de Faculteit Geneeskunde/St. Radboud Ziekenhuis. Van 
1987 tot 1989 volgde een aanstelling als wetenschappelijk medewerkster op de afdeling 
Gynecologic In 1990 werd de overstap gewaagd naar een eigen bedrijf, waar zij zich tot 
op heden bezig houdt met onderzoek op het gebied van milieuverontreinigende stoffen en 
met name de immunochemische analyse hiervan. 
157 
